METHODS FOR IDENTIFYING HERBICIDAL AGENTS THAT INHIBIT D1 PROTEASE

Abstract: D1 protease has been isolated from the alga (Scenedesmjus obliquus), wheat, and Synechocystis PCC 6803 and the genes encoding these enzymes have been cloned and sequenced. Native or recombinantly produced enzyme has been used to develop assays to detect herbicidal compositions capable of inhibiting the D1 protease enzyme.

Description: METHODS FOR IDENTIFYING HERBICIDAL AGENTS THAT INHIBIT Dl PROTEASE FIELD OF INVENTION The present invention relates to the field of molecular biology and, in particular, to a method to identify a new herbicidal target, Dl protease, necessary for the processing of the Dl protein found in the photosystem II reaction center of all higher plants. The invention further relates to methods for identifying herbicidal agents that will inhibit Dl protease, and methods and genes useful for the recombinant production of D 1 protease. BACKGROUND The Photosystem II (PSII) reaction center contains two homologous polypeptides, Dl and D2, that are responsible for the coordination of the primary photoreactants [Satoh, K. (1993) in The Photosynthetic Reaction Center (Deisenhofer, J. and Norris, J. R., eds.) Vol. I, pp. 289-318, Academic Press, New York; Seibert, M. (1993) in The Photosynthetic Reaction Center (Deisenhofer, J. and Norris, J. R., eds.) Vol. I, pp. 319-356, Academic Press, New York]. The Dl polypeptide of PSII is present in all organisms that use oxygenic photosynthesis to fuel metabolism. The source of electrons for the electron transport chain of oxygenic photosynthetic organisms is water. The oxidation of water to molecular oxygen occurs on a tetranuclear manganese cluster that is thought to be associated with the Dl polypeptide [Nixon et al, Biochem. 31, 10859-10871 (1992)]. Dl is expressed in precursor form [Grebanier et al., J. Cell Bio , 78, 734, (1978); Reisfeld et al., Eur. J. Biochem., 124, 125, (1992); Minami, J. B. and Watanabe, A. Plant. Cell Physiol. 26, 839-846 (1985)], inserted into the thylakoid membrane, and processed at its C-terminus [Marder et al., J. Biol. Chem. 259, 3900-3908 (1984); Diner et al., J. Biol. Chem. 263, 8972-8980 (1988); Nixon et al., Biochem. 31, 10859-10871 (1992)]. In cyanobacteria 16 residues are cleaved from precursor Dl (pre-Dl) [Nixon et al., (1992), supra] whereas 9 residues are cleaved in higher plants (Takahashi et al., FEBS Lett. 240, 6-8 (1988); Takahashi et al., Plant Cell Physiol. 31, 273-280 (1990)), with processing occurring in all cases at the carboxy side of Dl-Ala344. It has been suggested that this processing is effected by a protease enzyme, Dl protease. Failure to process the carboxy-terminal extension of pre-Dl results in the inability to fully assemble the manganese cluster necessary for photosynthetic water oxidation [Diner et al., J. Biol. Chem. 263, 8972-8980 (1988); Taylor et al., FEBS Lett. 235, 109-116 (1988)]. As the oxidation of water is absolutely essential to photosynthesis, prevention of this process prevents photoautotrophic growth of all cyanobacteria, algae and higher plants. Agents that inhibit the C-terminal processing of the Dl protein represent herbicidal candidates. Although several proteins termed "Dl protease" as well as genes ostensibly encoding Dl protease enzymes have been isolated from cyanobacteria, algae, and higher plants, there is no evidence until now that these enzymes are responsible for in vivo C-terminal processing of the Dl polypeptide. For example, Shestakov et al. [J. Biol. Chem. 269, 19354-19359 (1994)] and Anbudurai et al. [Proc. Natl. Acad. Sci, USA 91, 8082-8086 (1994)] teach the isolation of the ctpA gene from the cyanobacterium Synechocystis, a mutation which impairs the C-terminal processing of the pre-D 1. The characterization of this gene as encoding a Dl protease was made on the basis of the impairment, measured in vivo of pre-Dl processing in vivo and not on the basis of enzyme activity since no protein associated with this gene has as yet been isolated. Further studies by Applicants have shown, however, that the inactivation of the ctpA gene does not completely remove the ability of the mutant strain to process D 1 , suggesting that this protein is not wholly responsible for Dl processing. An enzyme demonstrating Dl protease activity in vitro has been isolated from spinach [Fujita et al., Plant Cell Physiol. 36(7) 1169-1177 (1995)] and the gene encoding the enzyme has been cloned and sequenced [Inagaki et al., Plant Mol. Biol., 30(1), 39-50 (1996)]. In vitro assays have shown that the spinach enzyme is capable of using a C-terminal fragment of the pre-Dl protein (consisting of 24 amino acids) as a substrate, but there has been no demonstration of a link between this enzyme and the in vivo processing of the pre-Dl protein [Taguchi et al., J Biol. Chem., 270(18), 10711-16 (1995)]. Pre-Dl protein processing activities have been isolated and partially purified from Scenedesmus and Pisum, [Packer et al., Curr. Res. Photosyntk, Proc. Int. Conf. Photosynth., 8th (1990), Meeting Date 1989, Volume 3, 759-62. Editor(s): Baltscheffsky, Margareta. Publisher: Kluwer, Dordrecht, Neth.] and from maize [Magnin et al., Res. Photosyntk, Proc. Int. Congr. Photosynth., 9th (1992), Volume 2, 211-14. Editor(s): Murata, Norio. Publisher: Kluwer, Dordrecht, Neth.]. These enzymes demonstrated activity in an in vitro PSII particle assay; however, no demonstration of in vivo activity of these enzymes has been obtained until now. Isolation of an enzyme from a plant that has pre-Dl processing activity is not de facto evidence that it is indeed responsible for in vivo pre-Dl protein processing. For example, an enzyme contained in periplasmic lysates of E. coli tail-specific protease has been identified [Silber et al., Proc. Natl. Acad. Set, USA 89, 295-299 (1992); Hara et al, J. Bacteriol. 173, 4799-4813 (1991)] that has about 30% identity to the putative Dl protease. Further, an enzymatic activity has been isolated by the Applicants from periplasmic isolates which has pre-Dl protein processing activity in vitro. While it is probable that these are one and the same enzyme, E. coli does not contain Dl and does not perform oxygenic photo- synthesis. Therefore, it cannot be concluded that an enzyme is Dl protease purely on the basis of its homology to known Dl protease-encoding genes and evidence of in vitro activity. Thus, in order to develop a method for the screening of herbicidal agents that target Dl protease, one problem to be solved is to positively identify the enzyme that is responsible for in vivo processing of the pre-Dl protein. Methods for assaying the presence of pre-Dl protein processing activity are known. For example, Hunt et al., [Res. Photosyntk, Proc. Int. Congr. Photosynth., 9th (1992), Volume 2, 207-10. Εditor(s): Murata, Norio. Publisher: Kluwer, Dordrecht, Neth.] teach an assay system using a truncated peptide substrate based on the C-terminal region of the Dl protein. Similarly, Packer et al., (Curr. Res. Photosyntk, Proc. Int. Confi Photosynth., supra) describe an assay using PSII thylakoid particles from the Scendedesmus Dl protease-deficient mutant LF-1. LF-1 PSII particles are incubated with a solution extracted from sonicated wildtype Scenedesmus thylakoids and Dl is processed to its normal mature size where the Mn complex is then photoligated and the photooxidation of water is detected. Finally, Taguchi et al., [J. Biol. Chem., 270(18), 10711-16 (1995)] teach an assay method using purified spinach Dl protease and either in vitro truncated Dl protein or synthetic oligopeptides, both containing the Dl C-terminus as a substrate. Enzyme products are identified by gel shift analysis and HPLC, respectively. Although assay methods such as these are useful for the detection of pre-Dl processing activity, they are not readily adaptable for commercially useful high throughput screens because they use large quantities of enzyme, rely on identification of enzyme substrate by either gel or HPLC analyis, and take hours to give results. Additionally, assays using truncated Dl as substrates (Hunt et al., supra; Taguchi et al., supra) must run the assay at a pH higher than that at which the enzyme functions in vivo. Another problem to be solved then is to develop an assay system that is facile and adaptable to high through-put screening. SUMMARY OF THE INVENTION The invention provides an in vitro method for identifying a herbicidal agent which inhibits Dl protease comprising: a) incubating an effective amount of a Dl protease in a sample suspected of containing a herbicidal agent with a suitable Dl enzyme substrate wherein an enzyme product is formed; and b) detecting and quantifying the enzyme product formed. The invention further provides an in vivo method for detecting a herbicidal agent which inhibits Dl protease comprising (a) incubating a reaction mixture containing (i) a wildtype cell having (A) an active Dl protease enzyme capable of processing a Dl pre-protein; and (B) a Photosystem II core complex capable of variable fluorescence; (ii) a suspected herbicidal agent which inhibits Dl protease; and (iii) suitable growth medium for a time sufficient to permit Dl turnover; then (b) illuminating the reaction mixture at illumination conditions of about 200 μ Einsteins.m" 2 .s _1 for a time sufficient to permit Dl turnover; and (c) measuring variable chlorophyll fluorescence produced in step (b), whereby the level of the variable chlorophyll fluorescence is correlated with the herbicidal activity of the suspected herbicidal agent. In a further embodiment of the in vivo detection method, the reaction mixture may also contain a mutant cell containing an inactive Dl protease enzyme characterized by an inability to process a Dl pre-protein and a Photosystem II core complex capable of variable chlorophyll fluorescence. This mutant cell is used as a control and is preferably LF-1 Scenedesmus. It is further within the scope of the invention to provide a method for the recombinant production of Dl protease enzyme comprising: (a) transforming a suitable host cell with a vector comprising a gene encoding a Dl protease enzyme, the gene operably connected to suitable regulatory sequences; (b) growing the transformed cell under conditions wherein Dl protease is expressed; and (c) recovering the expressed Dl protease. Finally the invention provides genes encoding Dl protease enzymes which encode the amino acid sequences of SEQ ID NOS: 4, 9, 13, and 15 wherein the amino acid sequences may encompass amino acid substitutions, deletions or additions that do not alter the function of the D 1 protease. BRIEF DESCRIPTION OF THE FIGURES. BIOLOGICAL DEPOSITS. AND SEQUENCE LISTING Figure 1 is a plot of Scenedesmus Dl protease enzyme activity versus enzyme concentration. Figure 2 is a plot of a time course of a D 1 protease assay. Figure 3 is a gel showing the migration as a single band of Dl protease from Scenedesmus following the complete purification procedure. Figure 4 shows an alignment of tryptic fragments with full length translated Dl protease gene from Scenedesmus. Figure 5 shows a composite diagram of primer locations and amplification products used to clone and sequence the Scenedesmus Dl protease gene. Figure 6 shows the translated nucleotide sequence for a 60 base region of the Dl protease gene from three strains of Scenedesmus. Applicants have made the following biological deposit under the terms of the the Budapest Treaty on the International Recognition of the Deposit of Micro-organisms for the Purposes of Patent Procedure: Depositor Identification Int'l Depository Reference Designation Date of Deposit Escherichia coli THSD1P ATCC 98186 26 September 1996 containing the wheat Dl protease gene As used herein, "ATCC" refers to the American Type Culture Collection international depository located at 12301 Parklawn Drive, Rockville, MD 20852 U.S.A. The "ATCC No." is the accession number to cultures on deposit with the ATCC. Applicant(s) have provided 29 sequence listings in conformity with 37 C.F.R. 1.821-1.825 and Appendices A and B ("Requirements for Application Disclosures Containing Nucleotides and/or Amino Acid Sequences") and in conformity with "Rules for the Standard Representation of Nucleotide and Amino Acid Sequences in Patent Applications" and Annexes I and II to the Decision of the President of the EPO, published in Supplement No. 2 to OJ EPO, 12/1992. DETAILED DESCRIPTION OF THE INVENTION Applicants have identified a novel herbicide target, Dl protease, and realized the use of purified Dl protease from recombinant and native sources in assay systems to identify herbicidal agents targeting Dl protease. These methods will facilitate the development of new products by the agricultural industry and have the potential for increasing the current understanding of the mechanisms by which the Photosystem II core complex (PS II) reaction center performs its photosynthetic functions. Applicants are the first to isolate and purify a pre-Dl processing enzyme and demonstrate that the enzyme has both in vitro and in vivo functionality. Applicants have purified the Dl protease enzyme to homogeneity from the alga, Scenedesmus obliquus, cloned the gene on the basis of amino acid sequence, identified conserved residues that likely correspond to the active site of the enzyme, and have shown that a mutation in this gene results in the loss of in vivo Dl protease activity. Applicants have developed an ELISA immunoassay that uses unprocessed Dl included in the thylakoid membranes or PSII core complexes isolated from the LF-1 mutant of Scenedesmus as substrates. Processing is detected by the progressive appearance of the mature C-terminus of the Dl protein that is specifically recognized by an antibody. This assay is fast, automatable, allows for multiple assays to be run simultaneously, uses amounts of enzyme in the 10 femtomolar range and, in the case of thylakoid membranes, may be operated at physiological pH (i.e., about pH 4-6), similar to that found for the in vivo Dl processing system. A method for the recombinant production of D 1 protease has also been developed. Although the gene encoding spinach Dl protease has been isolated previously, to date there is no report of recombinant production of this enzyme by others. Expression of recombinant Dl protease proceeded first by the isolation and purification of the enzyme from a suitable source, amino acid sequencing, synthesis of appropriate PCR primers based on the amino acid sequence, amplification of cDNA, cloning and isolation of the gene, and insertion of the gene into suitable expression vectors for the transformation and expression of the gene in recombinant hosts. As used herein the following terms may be used for interpretation of the claims and specification. "Gene" refers to a nucleic acid fragment that expresses a specific protein, including regulatory sequences preceding (5' non-coding) and following (3' non- coding) the coding region. "Chimeric" gene refers to a gene comprising heterogeneous regulatory and coding sequences. A "foreign" gene refers to a gene not normally found in the host organism but that is instead introduced by gene transfer techniques. "Coding sequence" refers to a DNA sequence that codes for a specific protein and excludes the non-coding sequences. As used herein, suitable "regulatory sequences" refer to nucleotide sequences located upstream (5'), within, and/or downstream (3') to a coding sequence, which control the transcription and/or expression of the coding sequences, potentially in conjunction with the protein biosynthetic apparatus of the cell. These regulatory sequences include promoters, translation leader sequences, transcription termination sequences, and polyadenylation sequences. "Promotor" refers to a DNA sequence in a gene, usually upstream (5') to its coding sequence, which controls the expression of the coding sequence by providing the recognition for RNA polymerase and other factors required for proper transcription. A promotor may also contain DNA sequences that are involved in the binding of protein factors which control the effectiveness of transcription initiation in response to physiological or developmental conditions. "Constitutive promotors" refers to those promotors that direct gene expression in all tissues and at all times. "Inducible promotors" refer to those promotors which turn on the description of a gene in the presence of an inducer. The term "operably linked" refers to nucleic acid sequences on a single nucleic acid molecule which are associated so that the function of one is affected by the other. For example, a promoter is operably linked with a structural gene when it is capable of affecting the expression of that structural gene (i.e., that the structural gene is under the transcriptional control of the promoter). The term "expression" refers to the production of the protein product encoded by a gene. The terms "protein" and "polypeptide" will be used interchangeably. The terms "Dl pre-protein", "Dl pre-polypeptide", and "pre-Dl" refer to the D 1 precursor protein that has been N-terminally processed but contains an additional 8 to 16 amino acid residues at the C-terminal portion of the protein which are cleaved off by Dl protease at the carboxy side of Dl-Ala344 to yield the mature Dl protein. The terms "Dl protein", "Dl polypeptide", and "mature Dl protein or polypeptide" refer to an electron transport polypeptide that is both N- and C-termmaliy processed and a subunit of the PSII reaction center. This polypeptide is implicated in coordinating a tetranuclear manganese (Mn) cluster which is found in the PSII reaction center of all photosynthetic organisms and is responsible for the coordination of the primary photoreactants. The term "psbA" refers to the gene encoding the Dl protein. The term "PSII core complex" refers to a multisubunit pigment-protein complex that consists of a PSII reaction center complex and two light-harvesting chlorophyll-proteins (CP47 and CP43). The term "Dl protease" refers to an enzyme responsible for the processing of the Dl pre-protein at the C-terminal end for the production of the mature Dl polypeptide. The terms "C-terminal tail" and "C-terminal tail fragment" refer to that portion of the C-terminal end of the Dl pre-protein that is cleaved off by Dl protease. The C-terminal tail fragment may comprise from about 8 to about 16 amino acid residues depending on the species from which it is isolated. The terms "Photosystem II reaction center", "photosystem II", and "PSII" refer to a multisubunit pigment-protein complex in the thylakoid membrane in the chloroplasts of higher plants, algae, and in cyanobacteria. The Photosystem II reaction center contains the Dl polypeptide. A general review of the properties of PSII maybe found in Vermaas et al., Cell Cult. Somatic Cell Genet. Plants (1991), Volume 7B, 25-111. Editor(s): Bogorad, Lawrence; Vasil, Indra K. Publisher: Academic Press, San Diego, California. The term "Dl turnover" refers to the degradation, biosynthesis, and reincorporation of Dl into the PSII reaction center. The term "RACE" refers to rapid amplification of cDNA ends and describes a process used in the art of molecular biology to amplify either end of a target cDNA from a cDNA population. The RACE method is fully described in the EXAMPLES. As used herein "Fv" means the variable fluorescence yield of chlorophyll emitted by PSII where fluorescence yield is determined by the redox state of the primary quinone electron acceptor, Qa. The term "Fo" refers to the lower limit of variable fluorescence (Fv) when Qa is fully oxidized. The term "Fm" refers to the upper limit of variable fluorescence (Fv) when Qa is fully reduced. The term "Fi" refers to Fv detected by the first photons absorbed or weak light illumination following dark adaptation. The term "weak light illumination" refers to < 0.1 photon per sec per center. The term "Qa" will refer to the the primary quinone electron acceptor for photosystem II. "Transformation" herein refers to the transfer of a foreign gene into the genome of a host organism or cell and its genetically stable inheritance. The term "plasmid" or "vector" as used herein refers to an extra chromosomal element often carrying genes which are not part of the central metabolism of the cell, and usually in the form of circular double-stranded DNA molecules. The term "restriction endonuclease" refers to an enzyme which binds and cuts within a specific nucleotide sequence within double-stranded DNA. "Host cell" means the cell that is transformed with the introduced genetic material. METHODS OF SCREENING FOR HERBICIDAL AGENTS The invention provides methods of screening for compounds and agents that possess herbicidal activity by specifically interfering with the Dl protease. These assays may take a variety of formats but all rely on detecting the effective C-terminal processing of a pre-Dl or a pre-Dl fragment. The assays developed include an ELISA-based method as well as various methods adaptable for a high- throughput screen of compounds. Assay Reagents All assays used a variety of reagents including Dl protease, a Dl protease substrate, a primary antibody having binding affinity for the enzyme product, and an enzyme reporter conjugated to the antibody. Optionally, a secondary antibody may be used having binding affinity for the primary antibody. The enzyme reporter may be conjugated to either the secondary or primary antibody depending on the assay format. Source of Dl protease It is contemplated that any higher plant, algal or cyanobacterial organism that performs oxygenic photosynthesis will contain functional Dl protease to process Dl of the Photosystem II reaction center. Dl protease may be isolated from any such source for use in assay systems or to isolate genes useful for recombinant expression of the protein. Potential sources of Dl protease include, but are not limited to, soybean, rapeseed, sunflower, cotton, corn, tobacco, alfalfa, wheat, barley, oats, sorghum, rice, cruciferous vegetables, broccoli, cauliflower, cabbage, parsnips, tomato, potato, spinach, alfalfa, sorghum, hardwood and softwood trees, forage grasses, as well as from algae, and cyanobacteria. The Dl protease will possess the ability to process the Dl pre-protein at the C-terminal end for the production of the mature Dl polypeptide. Dl protease may be isolated from natural sources or be produced recombinantly as described herein. Preferred in the present assays is Dl protease isolated from spinach, wheat, tobacco, algae, and cyanobacteria. Isolation And Purification Of the Dl Enzyme The Dl protease may be isolated from plant tissue using a series of chromatographic and separation techniques useful for the purification of proteins [See, for example, Berot et al., Proteines Veg. (1985), 335-472 Publisher: Tech. Doc. Lavoisier, Paris, France.] Isolated and purified spinach Dl protease is known [Fujita et al., Plant Cell Physiol., 36(7), 1169-77 (1995)] from extracts of sonicated spinach thylakoids using a series of chromatographic systems including chromatography on quaternary aminoethyl anion-exchange, hydroxylapatite, copper-chelating affinity and gel-filtration columns. Dl protease was purified from wheat, the algae Scenedesmus, and the cyobacterium Synechocystis PCC 6803 by isolating the thylakoid membranes containing the PSII reaction center and subsequent purification by Hydroxylapatite, Hydrophobic Interaction, MonoQ ion exchange, Isoelectric Focusing, and gel filtration chromatography. Confirmation of Applicants' isolation of Dl protease was made on the basis of the demonstration of pre-Dl processing activity as determined by both in vivo and in vitro assays. Cloning and Sequencing N-terminal sequencing was performed on tryptic digests of purified wheat or algal protease. Methods for amino acid sequencing are known in the art [See, for example, Hunkapiller et al. (Front. Biochem. Biophys. Stud. Proteins Membr., Proc. Int. Conf. (1983), Meeting Date 1982, 23-36. Editor(s): Liu, Teh- Yung. Publisher: Elsevier, New York, NY) for a general review of Edman degradation, and Kasarda (U.S. Agric. Res. Serv., North Cent. Reg., Rep. (1976), ARS-NC-40, 175-80) for an example of amino acid sequencing of wheat proteins]. Amino acid sequence was used to design degenerate primers for the PCR amplification of cDNA (U.S. Patent 4,683,202; U.S. Patent 4,683,195). Total mRNA was extracted from the plant or algal tissue using methods well known in the art [Sambrook et al., Molecular Cloning: A Laboratory Manual, Second Edition (1989) Cold Spring Harbor Laboratory Press] and the Oligo dT-primer cDNA was synthesized. Depending on the primers used, amplification of the cDNA gave either partial or full length PCR products from Scenedesmus and wheat as determined by gel electrophoresis. Full length cDNA amplification products were sequenced using well known base sequencing techniques [Branza-Nichita, Norica, Stud. Cercet. Biochim., 38(1-2), 49-56 (1995); Cantor et al., Mass Spectrom. Biol. Sci. (1996), 519-33. Editor(s): Burlingame, A. L.; Carr, Steven A. Publisher: Humana, Totowa, NJ] and inserted into suitable transformation vectors for expression. Host cells Suitable host cells for the recombinant production of Dl protease may be either prokaryotic or eukaryotic and the selection of a suitable host cell will be limited only by its ability to express an active enzyme. Preferred cells will be those typically useful for over-expression of foreign proteins such as E. coli, Bacillus, Klebsiella, fungi (e.g., Aspergillus), insects and yeasts (e.g., Pichia, Hansenula and Saccharomyces). E. coli is the most preferred host. Growth Conditions Cells used in the present invention include preferred host bacterial cells (for recombinant expression of Dl protease) and leaves, algal cells and cyanobacteria cells (for enzyme purification and Dl protease assays). Growth conditions for all cell types used are commonly available and well known in the art. Typically bacterial cells are grown at 30 °C in appropriate media. Preferred growth media in the present invention are common commercially prepared media such as Luria Bertani (LB) broth, or Sabouraud Dextrose (SD) broth. Suitable media used for Scenedesmus and Synechocystis was NGY medium [Bishop, Methods Enzymol. 23, 372-408 (1971)] and BG11 (Ripka et al., J. Gen. Microbiol. (1979) 111, 1-61 respectively, although any media that will support the growth and metabolism of the particular organism(s) sought to be grown will suffice. Other defined or synthetic growth media may also be used and the appropriate medium for growth of the particular organism will be known by one of ordinary skill in the art of microbiology or fermentation science. Suitable pH ranges for the cultures are between pH 5.0 to pH 9.0 where pH 6.0 to pH 8.0 is preferred as the initial condition. Vectors The present invention provides a variety of plasmids or vectors suitable for the cloning and transformation of the Dl protease enzyme into a suitable host cell. Suitable vectors will be those which are compatible with the host cell employed. Suitable vectors can be derived, for example, from a bacteria, a virus (such as bacteriophage T7 or a M-l 3 derived phage), a cosmid, a yeast or a plant. Protocols for obtaining and using such vectors are known to those of ordinary skill in the art [Sambrook et al., Molecular Cloning: A Laboratory Manual - volumes 1, 2, 3 (Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1989)]. Typically, the vector contains sequences directing transcription and translation of the protease gene, a selectable marker, and sequences allowing autonomous replication or chromosomal integration. Suitable vectors comprise a region 5' of the gene which harbors transcriptional initiation controls, and a region 3' of the DNA fragment which controls transcriptional termination. It is most preferred when both control regions are derived from genes homologous to the transformed host cell although it is to be understood that such control regions need not be derived from the genes native to the specific species chosen as a production host. Initiation control regions, or promoters, which are useful to drive expression of the Dl protease gene in the desired host cell are numerous and familiar to those of ordinary skill in the art. Virtually any promoter capable of driving the gene encoding the desired protein is suitable for the present invention. The T7 promoter is preferred. Termination control regions may also be derived from various genes native to the preferred hosts. Optionally, a termination site may be unnecessary, however, it is most preferred if included. For intracellular production of the desired protein, DNA encoding the protein is linked operably through its initiation codon to the selected expression control region such that expression results in the formation of the appropriate messenger RNA. Alternatively, if production of a fusion protein is desired, DNA encoding for the desired protein is linked at its 5' end to the 3' end of the gene encoding the carrier protein. Optionally, the reverse orientation could be constructed where DNA encoding the carrier protein is linked at its 5' end to the 3' end of the DNA encoding the desired protein. Also, if desired, DNA coding for an enzyme-cleavable site may be incorporated without reading frame disruption, between the DNA encoding the desired protein and the carrier-encoding DNA, so that expression yields a fusion protein from which the desired protein can be liberated by proteolytic enzyme cleavage. An example of the fusion protein approach to protein production is provided by Contreras et al, [Bio Technology, 9, 378 (1991)]. Preferred within the context of the present invention are commercially available vectors such as pET-32 vector (Novagen, Madison, WI). Transformation and Expression of Dl protease Once suitable vectors are constructed they are used to transform the desired host cells. Introduction of the gene cassette containing the Dl protease gene into E. coli may be accomplished by known procedures such as by transformation, e.g., using calcium-permeabilized cells, electroporation, or by transfection using a recombinant phage virus [Sambrook et al., supra], The pET-32 vector containing the Dl protease gene from wheat was used to transform E. coli BL21(DE3)pLysS competent cells according to standard protocols. Expression of the gene was monitored by determining the intensity of the corresponding stained band following SDS-PAGE. Enzyme Substrates Suitable enzyme substrates for Dl protease may be isolated from a variety of plant sources provided that Dl processing is prevented. Suitable plant sources include, but are not limited to, higher plants such as soybean, rapeseed, sunflower, cotton, corn, tobacco, alfalfa, wheat, barley, oats, sorghum, rice, cruciferous vegetables, broccoli, cauliflower, cabbage, parsnips, tomato, potato, spinach, alfalfa, sorghum, hardwood and softwood trees, forage grasses, as well as from algae and cyanobacteria. The preferred source for use in the present invention is mutant LF-1 Scenedesmus cells, possessing a mutant, non-functional Dl protease. The substrate may be purified Dl pre-protein, may be partially purified, or may be used as contained within the thylakoid membrane or within a PSII core complex. Additionally, the substrate may be a synthetic peptide or peptide analogue (la) containing a portion of the Dl pre-protein comprising the processing site. Alternatively, the substrate may be produced recombinantly via the expression of partial or full length genes coding for some part of the Dl polypeptide. At least for higher plant Dl protease, the enzyme assay can be performed at physiological pH (pH 4-5) only when the thyalkoid membrane containing Dl pre-protein is used as the enzyme substrate. Antibodies In a preferred embodiment of the assay, antibodies were directed to a synthetic peptide comprising the final 16 residues of all known mature Dl polypeptides. The peptide was conjugated to a carrier protein and antibodies were raised in rabbits according to standard methods (see, for example, Hayes et al., Methods EnzymoL, 187:116-24 (1990)). Antibodies can be either primary, having affinity for the enzyme product, or secondary, having affinity for the primary antibody, depending on the assay format. Either primary or secondary antibodies may be linked to a reporter enzyme. A variety of reporter enzymes may be used. For example, suitable reporter enzymes include, but are not limited to, hydrolases, lyases, oxido- reductases, transferases, isomerases and ligases. Others are peroxidase, glucose oxidase, phosphatase, esterase and glycosidase. Specific examples include alkaline phosphatase, Upases, beta-galactosidase, horseradish peroxidase and porcine liver esterase. Preferred in the instant invention are alkaline phosphatase (AP) and horseradish peroxidase (HRP). In embodiments where enzymes serve as reporters the substrate/enzyme reaction forms a product which results in a detectable signal, typically a change in color, fluorescence or chemiluminescence. In many cases chromogenic substances are an additional requirement for the color reaction. Chromogenic reagents are chosen on the basis of the reporter enzyme used. Some typical enzyme/chromogen pairs include, but are not limited to, β-galactosidase with potassium ferrocyanide or potassium ferricyanide; horse-radish peroxidase with 3,3' diaminobenzidine (DAB); Glucose oxidase with NBT; and alkaline phosphotase withNBT and 5-bromo-4-chloro-3-indolylphosphate-4-toluidine (BCIP) or p-nitrophenylphosphate (PNPP). Methods for the use of chromatogenic substance with enzyme reactions are well known in the art and are fully described by Tijssen [Practice and Theory of Enzyme Immunoassays in Laboratory Techniques in Biochemistry and Molecular Biology., eds., R. H. Burton and P. H. Van Knippenberg, (1988)]. Similarly, an example of an enzyme/substrate combination that produces a fluorescent signal is the enzyme alkaline phosphatase and the substrate Attophos [JBL Scientific Inc., San Luispo, CA] or HRP and N-acetyl-3,7-dihydroxy- phenoxazine [Molecular Probes, Inc., Eugene, OR]. An example of an enzyme/substrate combination that produces a chemiluminescent signal is the enzyme HRP and the BM Chemiluminescence ELISA Reagent substrate [Boehringer Mannheim Corp., Indianapolis, IN]. Preparation of an antibody-enzyme reporter conjugate may be accomplished using methods well known to those skilled in the art. Suitable examples are found in Williams [J. Immun. Methods, 79, 261 (1984)]. Assay Formats In one embodiment, an ELISA format was used to assay for Dl protease. Dl protease was purified from Scenedesmus and the enzyme substrate consisted of a PSII core complex containing Dl pre-protein. Substrate cores were linked to a multi-well (96-well) microtiter plate; Dl protease was added to the wells for a fixed time period and product was analyzed by using the primary antibody (having binding affinity for the enzyme product) followed by a secondary antibody (having binding affinity for the primary antibody). The quantity of primary antibody attached to the product of the Dl protease reaction was detected through an enzyme linkage to the secondary antibody and the enzyme activity was measured colorimetrically to quantify Dl protease activity. Optionally, a primary antibody was prepared which was conjugated to an enzyme reporter, eliminating the need for the secondary antibody. This method fits the standard ELISA immunoassay format as detailed by Omesso [Lab. 2000, 9(8), 52-6 (1995)]. In an alternate embodiment, assay methods have been developed to detect different enzyme products. For example, the action of Dl protease on the Dl pre- protein generates a mature Dl protein and a C-terminal tail fragment. Applicants have developed assay methods to detect both of these products independently. In Applicants' assay for the detection of the mature protein, enzyme substrate was provided in the form of thylakoid membranes containing Dl pre- protein, for example, isolated from Scenedesmus LF1 mutant cells and Dl protease isolated and purified from wheat leaves. The assay was conducted in microtiter plate wells, being modified to include a permeable membrane that facilitated the separation of the enzyme reaction products. In this assay, mature Dl protein was detected using either a double (primary, secondary) antibody system or a single antibody having affinity for the mature protein and linked to an enzyme reporter. Applicants also developed an assay to detect the C-terminal tail enzyme product. Cleavage of the C-terminal tail from the Dl pre-protein results in a free C-terminal tail having a reactive primary amine group. Various molecular probes are known which react with primary amines and may be used for peptide labeling. Examples of such molecular probes include but are not limited to fluorescamine [Stein et al., Fluorescence News (1973), 7(2), 9-10 (1973)]; ATTO-TAG [Molecular Probes, Inc., Eugene, OR]; naphthalenedialdehyde/cyanide [Lunte et al, Curr. Sep., 10(1), 19-25 (1990)]; 3-(4-carboxybenzoyl)-2-quinoline- carboxaldehyde [Liu et al., Anal. Chem., 63(5), 408-12 (1991)]; isothiocyanate compounds [Stobaugh et al., U.S. Patent No. 4,891,323); 3-Benzoyl-2- quinolinecarboxaldehyde [Beale et al., Talanta, 36(1-2), 321-5 (1989)]; o-phthalaldehyde [Benson et al., Proc. Natl. Acad. Sci. U S. A., 72(2), 619-22 (1975)]; and ninhydrin [Udenfriend, U.S. Patent No. 3,689,221). Preferred molecular probes within the context of the present invention are fluorescamine and ATTO-TAG. The assay for the C-terminal tail enzyme product proceeds in a similar fashion to the assay for the mature protein, using thylakoid membranes and microtiter plates modified with the Durapore® membrane, except that the fluorescent molecular probe is reacted with the solution containing the cleaved C-terminal tail. An increase in fluorescence in this sample is an indication of Dl protease activity. In another embodiment, Applicants developed an assay system utilizing live algal or plant tissue for the detection of Dl protease activity. In a preferred embodiment wildtype Scenedesmus cells are used in the assay system. The wildtype cells have a normal, functional Dl protease and therefore process Dl pre-protein normally. The assay relies on the use of chlorophyll fluorescence yield (Fv) as an indicator of the extent of pre-Dl processing. The presence of an inhibitor in the assay system blocks processing and gives rise to a higher Fv at low light intensity (Fi), and a lower Fv at high light intensity, as compared to the uninhibited wildtype used as a control. Additionally, the assay system may be designed to incorporate the LF-1 mutant Scenedesmus (which lacks the ability to process the D 1 pre-protein) as a control. In this format the wildtype and mutant cells are used together in the assay system. Mutant cells have no Dl processing ability due to a defective Dl protease and thus show a lower Fv than that of the wildtype under strong illumination [Metz et al., Biochem. Biophys. Res. Comm. 94, 560-566 (1980)]. Another advantage to the use of LF-1 mutants as a control is that the Fi of LF-1 cell is 2-3 fold higher than that of the wildtype cell. Thus, when wildtype cells or cells from higher plants (i.e., duck weed) are illuminated for several hours in a suitable growth medium containing Dl protease inhibitor, an increase in Fi and an decrease in Fv is seen when measured at light intensity of 10-100 photons per sec per center. An alternate embodiment of the the invention is suggested by the construction of a deletion mutant of Synechocystis 6803 (SAL) [Nixon et al., Biochemistry 31 (1992) 10859-10871] which lacks the three copies of the psbA gene encoding the Dl polypeptide. SAL, incorporates into the Photosystem II reaction center a copy of the Dl polypeptide in which the last sixteen amino acid residues are missing. This polypeptide is therefore expressed in a form that in wild type only appears upon processing of the last sixteen residues by Dl protease. Despite the absence of the sixteen residue carboxy-terminal extension, this strain is able to grow photosynthetically (doubling time 20 h) and to evolve oxygen (200 μmole 02 # (mg of Chl" 1 )^" 1 ) at rates close to those of wild type. The availability of the SAL strain makes possible an in vivo assay for inhibitors that are specific for Dl protease. The assay consists of growing the wild type and the S^E strains side by side under photoautotrophic growth conditions (light intensity 30-50 and in the presence and absence of the inhibitor to be tested. The increase in cell density is measured at 730 nm as a function of time to determine the rate of cell growth. In the wild type strain, an inhibitor specific for Dl protease would block the C-terminal processing of the precursor form of the Dl polypeptide, thereby preventing assembly of the manganese cluster necessary for photosynthetic electron transport. Growth of the wild type strain would cease. In contrast, this inhibitor would have no effect on the growth rate of the SAL strain, which does not require Dl protease activity as the Dl polypeptide already lacks the C-terminal extension, the absence of which still allows photosynthetic growth. An inhibitor, not specific for Dl protease, would inhibit growth of both the wild type and SAL strains. The present invention is further defined in the following Examples, in which all parts and percentages are by weight and degrees are Celsius, unless otherwise stated. It should be understood that these Examples, while indicating preferred embodiments of the invention, are given by way of illustration only. From the above discussion and these Examples, one skilled in the art can ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions. EXAMPLES GENERAL METHODS Restriction enzyme digestions, phosphorylations, ligations and transformations were done as described in Sambrook, J. et al., Molecular Cloning: A Laboratory Manual, Second Edition (1989) Cold Spring Harbor Laboratory Press. The meaning of abbreviations is as follows: "h" means hour(s), "min" means minute(s), "sec" means second(s), "d" means day(s), and "L" means liter. Algal and Plant Strains as source of Dl Protease The algal strains used in this study were the wildtype of Scenedesmus obliquus, strain D 3 , and a non-photosynthetic low-fluorescent mutant (LF-1) derived from wildtype by X-ray mutagenesis [Metz et al., Biochem. Biophys. Res. Comm. 94:560-566 (1980)]. A photoautotrophic suppressor strain, derived from LF-1 (LF-l-RVT-1) [Bishop, (1983) In The Oxygen Evolving System of Photosynthesis. (Y. Inoue et al., eds.) pp. 177-187, Academic Press, New York], was also examined. All strains were kindly provided by Norman Bishop (Oregon State University, Corvallis, OR). Except where fermentors were used the cells were grown in 20 L carboys on NGY medium (Bishop, Methods Enzymol. 23:372-408 (1971)) in the light at 25 °C. Wheat plant tissue was obtained from wheat leaves Triticum aestivum. var. Fidel. Cyanobacterium Synechocystis Strain PCC6803 was obtained from the Pasteur Culture Collection, Institut Pasteur, Paris, France. Purification of Dl protease from Scenedesmus Membrane Extracts: Membranes containing Dl protease were extracted from wildtype cells of Scenedesmus obliquus tissue. Cells were suspended in 1 volume per weight of 20 mM HEPES-KOH, 10 mM KCl, 10% glycerol, and pH 7.25 (Buffer H) and centrifuged 5 min at 5000 rpm (4200 x g) in a GS-3 rotor. The pelleted cells were resuspended in 1 volume per weight in buffer H and stored at -80 °C until use. For a typical protease isolation, 1 L of cell suspension was thawed and processed through a micro fluidizer (model HOY; Microfluidics Corporation, Newton, MA) by using 4 passes (18-23,000 psi) with cooling in a wet ice bath between passes. The homogenate was centrifuged 10 min at 10,000 rpm (16,000 x g) in a Sorvall GSA rotor (Newtown, CT) to remove cell debris. The pellet was washed with buffer H to resuspend sedimented thylakoids and was added to the supernatant. The combined slurry was homogenized by stirring 30 min or by using a Teflon™/glass homogenizer. Thylakoids were collected by centrifuging 2 h (or overnight) in Beckman 45 Ti rotors at 45,000 rpm (235,000 x g). The pelleted thylakoids were resuspended in buffer H by using a Tefion™/glass homogenizer and brought to a concentration of 2 mg chlorophyll/mL and 0.5% by volume TRITON X-100 from a 20% aqueous stock. After stirring for 30 min, the thylakoids were centrifuged for 2 h at 45,000 rpm (235,000 x g) in a 45 Ti rotor. The TRITON X-100 supernatant was collected and stored on wet ice. The thylakoid pellet was resuspended in buffer H and brought to 2 mg/mL chlorophyll and 0.5% TRITON X-100. After stirring 30 min, it was centrifuged 2 h in a 45 Ti rotor at 45,000 rpm (235,000 x g). Hydroxylapatite Purification: The second TRITON X-100 supernatant was combined with the first and loaded onto a 5x35 cm column of hydroxylapatite (Fast flow, Calbiochem, San Diego, CA) that had been previously equilibrated with 10 mM K2HPO4/KH2PO4, pH 7.0, 10% glycerol. After loading (10 mL/min), the column was washed with 500 mL of equilibration buffer and 250-mL fractions were collected. This was followed by 1 L of 100 mM K2HPO 4 /KH2PO 4 , pH 7.0 andl0% glycerol and 50-mL fractions were collected and assayed. Fractions showning Dl protease activity were concentrated and submitted to hydrophobic interaction chromatography. Hydrophobic Interaction Purification: The hydrophobic interaction column (TSK-Gel Phenyl-5PW, 20 mm ID x 15 cm, TosoHaas) was preceded by a guard column of the same material (20 mm ID x 2 cm). The column was first washed at 3 mL/min for 20-30 min with buffer B (20 mM HEPES-KOH, pH 7.25 and 20% glycerol) and then equilibrated at 10 °C with 60% Buffer A (20 mM HEPES-KOH, pH 7.25 and 20% glycerol plus 2 M (NH 4 ) 2 SO 4 ):40% Buffer B at the same flow rate for 30-40 min. The sample was loaded onto the hydrophobic interaction column at 3 mL/min by using a Pharmacia Superloop. A linear gradient was then applied at 3 mL/min which went from 60%A:40%B to 20%A:80%B over the next 90 min. The run was completed by ramping up to 100%B over the following 20 min and maintained at that level for another 15 min. Three mL fractions were collected. Active fractions from the hydrophobic interaction column were pooled and concentrated by using a Centriprep 10 (Amicon) to 23 mL and passed through an Econo-Pac 10DG desalting column (Bio Rad, Melville, NY) previously equilibrated with Buffer B and used according to the manufacturer's instructions. Ion-Exchange purification: The approximate 4 mL sample was then loaded onto an HRlO/10 MonoQ column (Pharmacia, Pisscataway, NJ) at a flow rate of 1 mL/min, previously equilibrated with Buffer B. The column was subsequently washed for 10 min with 100% Buffer B followed by a linear gradient from 100% Buffer B to 100% Buffer C (Buffer B plus 0.5 M NaCl) over a period of 100 min and maintained at 100% Buffer C for 10 min, all at a flow rate of 1 mL/min. Two-mL fractions were collected and assayed> Active fractions were concentrated and submitted to isolectric focusing purification. Isoelectric Focusing Purification: Preparative isolelectric focusing was carried out in a BioRad Rotofer cell using 45 mL of 20% glycerol, 0.1 % CHAPS (3-[(3-cholamidopropyl)-dimethyl ammonio]-l-propane-sulfonate), 1% Servalyte 4-6 and 0.25% Servalyte 3-10. The cell was prerun for 1 h at 12 W to establish the pH gradient and following the addition of 4 mL of sample to the center well subsequently run for 3-4 h at 5 °C at 12 W. The enzyme migrated with an isoelectric point of 5.0±0.1. The fractions were collected and assayed. Active fractions were concentrated and submitted to gel-filtration chromatography. Gel-Filtration Purification: The Rotofer fractions were concentrated to about 50 μL by using a Centricon™ 10 (Amicon) and injected onto a TSK-Gel G4000SWXL column (8 μm particle size, 7.8 mm ID x 60 cm) previously equilibrated with Buffer D (Buffer B plus 100 mM NaCl). The column was run at 0.25 mL/min and 0.5 mL fractions were collected. Aliquots of each fraction were diluted 1 :4 or 1 :6 with Buffer B and assayed. The peak of activity appeared at about 92 min from the start of the run. A comparison with the elution times of a collection of standard proteins, run under the same conditions, gave an estimated molecular mass that ranged from 36-42 kDa. This agrees favorably with a molecular mass of 42±1 kDa based on SDS-PAGE (Figure 3) and a calculated [Genetics Computer Group (1994) In Program Manual for the Wisconsin Package, Version 8, Genetics Computer Group, Madison, WI] mass of 40,578 Da, based on the translated sequence of mature Dl protease (SEQ ID NO:4) from Scenedesmus. Purification of Dl protease from wheat: The purification of Dl protease from wheat followed essentially the same protocol as described above with the exception that the wheat chloroplasts were suspended in a hypotonic buffer (10 mM HEPES-NaOH, pH 7.3), and then the thylakoid membranes were isolated by centrifugation. The membranes were resuspended in 20 mM HEPES, 10% glycerol, pH 7.25, at 1 mg chlorophyll/mL. 0.5% TRITON X-100 was added to extract the Dl protease from the membrane. The wheat purification differed from the above protocol at the hydroxylapatite stage where, after loading the sample onto the column, the column was first washed with 200 mL of 50 mM Pi-buffer (pH 7.0). It was then eluted with a 500 mL linear gradient from 50 to 150 mM Pi-buffer/ 10% glycerol (DA 7.0). The column was further washed with 150 mM Pi-buffer and the eluents were collected by fraction collector (12 mL/ fraction), and each fraction was assayed for Dl protease activity. The protocol for wheat differed from the above procedure also at the ion- exchange purification stage where the following elution protocol was used: Time Solvent A Solvent B (min) (20 mM HEPES/20% glyercol, pH 7.25) (A+0.5 M NaCl) 0 100% 0% 10 100% 0% 10.01 80% 20% 40 80% 20% 130 40% 60% 130.1 0% 100% 140 0% 100% Finally, the gel filtration step was expanded to include a second gel filtration where, after the first gel filtration column step (TSK-Gel, G4000SWXL), the sample was further purified using a TSK-Gel G2000SWXL column. The conditions used for this step are the same as used for the first gel filtration column. Purification of Dl protease from Synechocystis 6803: Dl protease was isolated from thylakoid membrane of Synechocystis 6803 in a similar manner to the protocol used for purifying wheat Dl protease described above. The thylakoid membranes were isolated from the Synechocystis cells as described in Tang et al. [Biochemistry, 33, 4594-4603 (1994)]. All of the above column purification steps were performed at 4-10 °C. The yields of the various steps and their respective specific activities are listed in Tables 1-3 below. Purification to homogeneity was confirmed by a protein blot as shown in Figure 3, where a single band identified as Dl protease is seen to migrate at 42.7 kD. TABLE 1 SUMMARY OF THE PURIFICATION OF Dl PROTEASE FROM 500G OF SCENEDESMUS OBLIQUUS CELLS Activity Specific Activity Step (rel. units) Protein (rel. units) •Membrane extract nd ig nd •Hydroxylapatite pooled fractions 168,000 210mg 800 •Hydrophobic Interaction pooled fractions 49,000 20mg 2,440 •MonoQ pooled fractions 52,000 l.lmg 46,000 •Isoelectric Focusing pooled fractions 15,600 nd nd •Gel filtration pooled fractions 9,100 5-10μg 0.9-1.8xl0 6 nd = not determined TABLE 2 SUMMARY OF THE PURIFICATION OF Dl PROTEASE FROM 500G OF WHEAT LEAVES Specific Activity Activity Step (rel. units) Protein (rel. units) •Membrane extract nd 2 g nd •Hydroxylapatite pooled fractions 890,000 130 mg 6,846 •Hydrophobic interaction poole fractions 170,400 12 mg 14,200 •MonoQ pooled fractions 112,000 500 μg 224,000 •First gel filtration (TSK-Gel G4000SWXL) pooled fractions 96,000 70 μg 1.4 x lO 6 •Second gel filtration (TSK-Gel G2000SWXL) 90,000 10 μg 9.2 x lO 6 nd = not determined TABLE 3 SUMMARY OF THE PURIFICATION OF Dl PROTEASE FROM 500G OF CYANOBACTERIUM SYNECHOCYSTIS CELLS Specific Activity Activity Sterj (rel. units) Protein (rel. units) •Membrane extract nd 3-5 g nd •Hydroxylapatite pooled fractions 339,000 240 mg 1,412 •Hydrophobic interaction pooled fractions 53,238 10 mg 5,324 •MonoQ pooled fractions 42,820 400 μg 107,050 •First gel filtration (TSK-Gel G4000SWXL) pooled fractions 29,600 90 μg 3.3 x 10 5 •Second gel filtration (TSK-Gel G2000S XL) 19,200 21 μg 9.1 x lO 5 nd = not determined EXAMPLE 1 Cloning and sequencing of the Dl protease gene from Scenedesmus Preparation of purified enzyme for amino acid sequencing Dl protease was biochemically isolated from Scenedesmus as described above and prepared for amino acid sequencing. SDS-PAGE and blotting were carried out according to a protocol [Best et al., (1994) In Techniques in Protein Chemistry, Vol. V, pp. 565-574, Academic Press, New York) established by the Wistar Protein Microchemistry Laboratory (Philadelphia, PA)]. A 12% polyacrylamide gel (30:1.8 w/w, acrylamide:bisacrylamide) 1.5 mm thick was poured, polymerized and left to stand overnight at room temperature prior to use. SDS-PAGE was run according to Best et al. [supra] with the upper buffer chamber containing 0.2% SDS and 0.1 mM thioglycolate. The solubilizing buffer (2X) contained 0.2 M sucrose, 6% SDS, 125 mM Tris, 4 mM EDTA, 0.04% bromphenol blue and 2% b-mercapto- ethanol (v/v) adjusted to pH 6.9. This solution was added to an equal volume of concentrated protease solution and loaded onto the sample well of the polyacrylamide gel. The gel was run overnight at room temperature. The gel was then soaked for 25 min in Transfer Buffer composed of 10X Towbin buffer (250 mM Tris, 1.92 M glycine) + 400 mL MeOH diluted to 4 L with Milli-Q water. BioRad TransBlot PVDF membrane (0.2 μm) was soaked for 10 sec in methanol and then for 20 min in Transfer Buffer. Blotting was carried out in a BioRad liquid Trans-Blot Cell using the above indicated Transfer Buffer and according to the manufacturer's instructions. A current of 240 mA was applied for 3 h at room temperature. The blot was washed three times for 5 min each with Milli-Q water and then stained for 1 min with 0.1% Amido Black in 10% acetic acid in Milli-Q water. The blot was destained for 1 min with 5% aqueous acetic acid and washed thoroughly with Milli-Q water. The blot was air-dried and sent to the Wistar Protein Microchemistry Laboratory, Philadelphia, PA, for sequencing. Tryptic digest of the protein on the blot and subsequent HPLC purification of the tryptic fragments were performed as described in Laemmli [Nature, 227680-685 (1970)]. Degradative Edman sequencing was conducted at both the N-terminus and on selected HPLC purified tryptic fragments. In the latter case the MALDI (Matrix Assisted Laser Desorption Ionizaton) mass spectra were also obtained on the sequenced fragments as a confirmation of the sequence calls. The amino acid sequences obtained are shown in Figure 4. The various tryptic fragments for which amino acid sequence data were obtained are shown aligned with the translated full-length Dl protease sequence. The mature amino terminus is noted, as is the site of the LF-1 mutation. The resultant LF-1 amino acid sequence is shown below the wildtype sequence (an asterisk denotes a stop codon). Horizontal arrows show the location of degenerate primers used to recover the initial 770 bp fragment of the gene. Isolation of nucleic acid Total RNA was extracted from Scenedesmus by the following procedure: 35 g of frozen cell paste was ground with 80 mL of buffer G (8 M guanidine HC1, 20 mM EDTA, 20 mM MES pH 7.0 and 50 mM β-mercaptoethanol) in a PowerGen 125 tissue homogenizer (Fisher Scientific Pittsburgh, PA) for 60 sec set on high. The homogenate was extracted with 150 mL phenol/chloroform/ isoamyl alcohol (25:24:1), and then spun in a Sorvall GSA rotor for 45 min at 8000 rpm (10,400 x g) at 25 °C. The supernatant was recovered and the RNA precipitated with 0.2 volumes of 1 M acetic acid and 0.7 volumes of ethanol while at -20 °C, overnight. The RNA was pelleted by centrifuging in a GSA rotor at 10,000 rpm (16,300 x g) for 15 min at 4 °C. The pellet was washed twice with 10 mL of 3 M sodium acetate, pH 5.2, with a final rinse of 15 mL of 70% ethanol. The pellet was resuspended in 4 mL of RNAse-free water and stored at -70 °C until use. Poly-A containing messenger RNA was recovered from undiluted total RNA using the PolyATract system from Promega (Madison, WI), according to the manufacturer's instructions. The integrity of the RNA was confirmed by running on a 1% Tris-acetate agarose gel. Total chromosomal DNA was recovered from Scenedesmus by the following procedure: about 500 mg of cells were harvested from the surface of agar plates, and resuspended in 500 μL of TSE (5 mM Tris-HCl pH 8.5, 50 mM NaCl, and 5 mM EDTA). The resuspended cells were frozen dropwise in liquid nitrogen, then ground while frozen by using a mortar and pestle. Ground cells were suspended in 1.4 mL TSE, 40 μL proteinase K (2.5 mg/mL), 100 μL 20% SDS, and 100 μL 20% Sarkosyl. The mixture was incubated at 65 °C for 2 h, then extracted with 2 mL buffer-saturated phenol, and centrifuged for 15 min at 6,000 rpm (9400 x g) in a Sorvall HS-4 rotor. The supernatant was extracted with 2 mL chloroform and spun as above. The nucleic acids were precipitated from the extracted supernatant with 0.1 volume of 3 M sodium acetate, and an equal volume of isopropanol. The precipitate was pelleted by spinning at 6000 rpm (9400 x g) for 20 min in the HS-4 rotor, then dried, and resuspended in 900 μL TE (10 mM Tris-HCl pH 7.5, 1 mM EDTA) in microfuge tubes. RNA was digested with 20 units RNase-it (Stratagene, La Jolla, CA). Starches were removed by adding 300 μL of 7.8 M ammonium acetate and centrifuging 30 min at 12,000 x g. The DNA was precipitated by adding 1.8 mL isopropanol and centrifuging 30 min at 12,000 x g. The DNA was resuspended in 1 mL TE. Typical concentrations were 400 μg/mL. Cloning and sequencing The HPLC purified tryptic peptides of the Dl protease were sequenced as described above and were ordered by matching them to translated Dl protease genes from wheat. Degenerate oligonucleotide primers "A" (SEQ ID NO:l) and "B" (SEQ ID NO:2) were designed to prime regions of minimum degeneracy within the peptide fragments shown in Figure 5. Primers A and B were degenerate primers based on sequenced tryptic peptide fragments shown in Figure 6. The resulting 770 bp RT-PCR gene fragment yielded nucleotide sequence data used to design gene specific primers GSP- 1,2,3 and 4. For 5'RACE, cDNA was oligo-dC-tailed and the first round of PCR performed with the G-anchor primer and GSP-3. The second round of PCR used the G-anchor primer and GSP-4. For 3 'RACE, cDNA synthesis was primed with a special oligo-dT adapter primer which contains a region complementary to the Universal Amplification Primer (UAP). The first round of amplification was primed with UAP and GSP-1, the second round was primed with UAP and GSP-2. The spacing of the primers predicted a PCR (Polymerase Chain Reaction) product of about 770 bp. Oligo dT-primed cDNA was prepared from Scenedesmus polyA mRNA by using a BRL Superscript preamplification system from Gibco BRL (catalog no. 18089-011, Life Technologies, Inc., Gaithersburg, MD). This cDNA was used as template for a PCR primed with degenerate oligonucleotides "A" and "B". The amplification employed a "touchdown" cycle sequence (Don et al., Nucleic Acids Res. 19, 4008 (1991)] with the annealing temperature dropping by 2 degrees every 3 cycles, from 60 °C to 50 °C, followed by 15 cycles at 47 °C. The reaction product was electrophoresed in a Tris-acetate low-melting point agarose gel, and a faint band of about 770 bp was excised from the gel. The gel was melted at 70 °C and a 10 μL aliquot used as template in an identical repeat amplification reaction, except that a 30 min incubation at 72 °C was included to enhance the 3' addition of single deoxyadenosines by Taq™ polymerase (Hoffman-LaRoche, Ltd., Basel, Switzerland). This second amplification reaction produced a concentrated band of DNA that was excised from a low melt gel and ligated directly into a pGEM-T vector (Promega, Madison, WI), according to the supplier's instructions. Clones containing inserts of the expected 770 bp size were sequenced on an ABI 377 automated sequencer (Applied Biosystems, Foster City, CA). The nucleotide sequences of the cloned fragments permitted the design of exact gene- specific primers. The primers were then used for the Rapid Amplification of cDNA Ends (RACE) in conjunction with a 5'RACE kit (Cat. No. 18373-019) and a 3'RACE kit (cat. no. 18374-025) both from Gibco BRL, and used according to the manufacturer's instructions, except for the substitution of Expand High Fidelity polymerase (Boehringer Mannheim, Indianapolis, IN) in place of Taq™ polymerase (Hoffman-LaRoche, Ltd.). Reaction products were run on low melt agarose gels. The 5'RACE procedure produced an amplified DNA product that was 1 kb in length. The 3'RACE procedure yielded a product that was 1.4 kb in length. Both bands were excised. As the Expand High Fidelity polymerase generates blunt-ended fragments, the following step was included to add single deoxyadenosine tails. Twenty μL aliquots of each band were incubated at 72 °C for 30 min in the presence of 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl2, 0.33 mM dATP, and 0.5 units Taq™ polymerase (Hoffman-LaRoche, Ltd.). The tailed fragments were then ligated into a pGEM-T vector. A minimum of 4 independent clones were sequenced (both strands) for each of the 5'RACE and 3'RACE products of the LF-1 and wildtype cDNAs. Clones from the 5' end overlapped clones from the 3' end by 440 bases. Sequencing was performed as above, and the data managed using the Lasergene SeqMan program (DNASTAR Inc., Madison, WI). Multiple independent clones were sequenced as a precaution against mutations introduced during the course of DNA amplification. Applicants reasoned that a true mutation, present in LF-1 , would appear in all LF-1 clones and none of the wildtype clones, whereas amplification mutants would appear randomly. A mutation rate of 1 error per 2000 bases sequenced was still observed despite the use of a "high fidelity" polymerase. Once the nucleotide sequence difference between the Dl protease genes of LF-1 and wildtype was determined by sequencing the RACE clones, the mutation was verified in the Scenedesmus genome by PCR amplification and sequencing of the homologous region. Two μg each of chromosomal DNA from the wildtype, LF-1, and the suppressor strain, LF-1 RVT-1, were used as template. A pair of gene-specific primers 507 bp apart were used to prime the reaction, which used the "touchdown" cycle sequence method [Don et al., Nucleic Acids Res. 19(14):4008 (1991)]. The reaction products were run on a standard agarose gel, and the predominant band, running at 1200 bp, was excised. The fact that the genomic PCR product was 700 bp larger than expected indicates the presence of one of more introns. The DNA was recovered using GeneClean (Bio 101, La Jolla, CA), and sequenced as above using the same primers used for PCR. The sequence of the Scenedesmus Dl protease gene is given in SEQ ID NO: 3 and the amino acid sequence of the encoded protein is given in SEQ ID NO:4. EXAMPLE 2 Comparison of Scenedesmus Dl protease amino acid and nucleotide sequencing and confirmation of in vivo pre-Dl processing The 5' end of the mRNA from wildtype was determined by sequencing 5'RACE clones. A total of 21 were sequenced, and the three longest showed a consistent startpoint. The remaining clones were shorter and had random startpoints, presumably the result of incomplete cDNA synthesis. The first in-frame methionine was designated the start codon. Nucleotide sequencing of the wildtype Scenedesmus cDNA predicts a protein of 464 amino acids. Of these, the first 77 comprise a leader sequence as N-terminal amino acid sequencing of the mature protein indicated the first residue to be valine 78 (Figure 4). A thylakoid transit sequence can be discerned with basic residues (Lys39 and Arg40), 39 and 38 residues, respectively, upstream from the mature N-terminus, followed by a region of hydrophobic residues and terminating in a typical AXA lumenal processing site [von Heijne et al., Eur. J. Biochem. 180, 535-545 (1989); Shackleton et al., J. Biol. Chem. 266, 12152-12156 (1991)]. Upstream of the transit sequence is a region, enriched in serines and threonines, that is characteristic of a chloroplast signal sequence (Gavel et al., FEBS Lett. 261, 455-458 (1990)). Nucleotide sequencing of the cDNA isolated from the LF-1 mutant revealed a single base deletion in the glycine 387 codon that shifts the reading frame, causing a translation stop after 2 additional amino acids (Figure 6). The circled lysine shown in Figure 6 is a likely component of the active site of the protease. The parentheses show the site of the single G deletion in the LF-1 and revertant strains. An arrow identifies the site of a single T insertion in the LF-1 suppressor strain, LF-1 -RVT-1. The point mutation was confirmed in genomic DNA by using PCR to directly sequence a 500 bp region of the LF-1 mutant and wildtype genomes. In addition, the same region was sequenced from an LF-1 revertant strain (LF-l-RVT-1), which was shown to have a single base-pair insertion 7 bases downstream of the LF-1 deletion. This insertion restores the proper reading frame after two amino acids that differ from wildtype (Figure 6). EXAMPLE 3 Cloning and sequencing of the Dl protease gene from wheat Preparation of purified enzyme for amino acid sequencing Dl protease was biochemically isolated from wheat as described above and then prepared for amino acid sequencing. The purified enzyme was electrophoresed on SDS-PAGE according to Laemmli [(1970), supra]. The gel was stored for 24 h prior to use and 0.1 mM thioglycolate and 0.2% SDS was added to the running gel buffer. The protein was then transblotted to PVDF membrane in a BioRad Trans-Blot cell as described above and according to the manufacturer's instructions. The blot was stained with Amido Black and sent to the Wistar Microchemistry Core Facility, Philadelphia, PA, for sequencing. The band containing the Dl protease band, was cut out of the blot. The protein band was digested with trypsin and the fragments separated on a C-l 8 HPLC column according to Best et al. [(1994, Techniques in Protein Chemistry V, pp. 565-574, Academic Press, New York]. Mass spectra and N-terminal sequence were performed on the cleanest and largest peptide fragments. Isolation of Messenger RNA Wheat leaves were harvested when plants were 15 cm tall, and 4 h after exposure to light. The leaves were cut with sterile scissors and immediately frozen in liquid nitrogen. Total RNA was extracted from leaves by the following procedure: 35 g of crushed frozen leaves were ground with 80 mL of buffer G (8M guanidine HC1, 20 mM EDTA, 20 mM MES pH 7.0, 50 mM β-mercaptoethanol) in a PowerGen 125 tissue homogenizer (Fisher Scientific) for 60 sec at high speed. The homogenate was extracted with 150 mL phenol/chloroform/isoamyl alcohol (25:24: 1), and then spun in a Sorvall GSA rotor for 45 min at 8000 rpm at 25 °C. The supernatant was recovered and the RNA precipitated with 0.2 volumes of 1 M acetic acid and 0.7 volumes of ethanol while at -20 °C, overnight. The precipitate was pelleted by centrifuging 10,000 rpm, 15 min at 4 °C. The pellet was washed twice with 10 mL of 3 M sodium acetate, pH 5.2, with a final rinse of 15 mL of 70%) ethanol. The pellet was resuspended in 4 mL of RNAse-free water and stored at -70 °C until use. Poly-A containing messenger RNA was recovered from undiluted total RNA using the PolyATract system from Promega (Madison, WI), according to manufacturer's instructions. The integrity of the RNA was confirmed by running on a 1% Tris-acetate agarose gel. Reverse Transcriptase PCR Complementary DNA was prepared for use as template for PCR. To accomplish this, wheat poly-A mRNA was primed with the "reverse" primer GCNCC(GA)TCNGCCTCATA, (SEQ ID NO:29) based on the amino acid sequence data. The bases in parenthesis are the alternative bases used in the degenerate primer. Complementary DNA was synthesized with Superscript reverse transcriptase from Gibco BRL, following the manufacturer's instructions. For the first PCR, the "forward" degenerate primer was ATGGA(CT)AT(CT)TA(CT)GA(CT)GC (SEQ ID NO:5) and the "reverse" primer as shown above. Each primer concentration was 166 pMoles per 50 uL reaction. The amplification employed a "touchdown" cycle sequence (Don et al, Nucleic Acids Res. 19(14):4008 (1991)] with the annealing temperature dropping by 2 degrees every 3 cycles, from 60 °C to 50 °C, followed by 15 cycles at 47 °C. The reaction product was electrophoresed in a Tris-acetate low-melting point agarose gel, and a faint band of about 400 bp was excised from the gel. The gel was melted at 70 °C and a 10 uL aliquot was used as template for a second PCR amplification, using the above forward primer and an internally nested reverse primer, GC(TGA)AT(CT)TC(GA)AT(TGC)CC(CT)TC (SEQ ID NO:6). The second amplification reaction produced a concentrated band of about 300 bp DNA that was excised from a lowmelt gel and ligated directly into a pGEM-T vector (Promega, Madison, WI) according to the supplier's instructions. The resulting clone was sequenced to provide data for design of primers used for rapid amplification of c-DNA ends (RACE) and mRNA capture. The 3' end of the gene was cloned using a capture oligo strategy as follows. The biotinylated oligo (biotin- TCTGAACCTGGAATCTCACACATCCTTGA) (SEQ ID NO:7), based on the sequence of the above PCR clone and specific to the middle of the gene, was synthesized by the DuPont oligonucleotide facility (Wilmington, DE). The biotinylated oligonucleotide was hybridized to total mRNA and then bound to streptavidin magnetic beads (Dynal International, Oslo, Norway). The captured mRNA was used to synthesize c-DNA primed by oligo dT. After second strand synthesis, the ends were tagged with single overhanging 3 'deoxyadenosine residues by incubating with Taq™ polymerase (Hoffman-LaRoche, Basel, Switzerland). The tagged DNA was then ligated into a pGEM-T vector.as above. The ligated DNA was used to transform E. coli. Transformants were selected on LB agar plates containing Ampicillin and individual colonies were screened by gel electrophoresis for plasmids containing inserts. Inserts were identified by sequencing. An 850 bp fragment of the Wheat Dl protease gene was recovered. It contains the poly-A region, the stop codon and more than half of the coding region, and overlaps the 300 bp PCR clone by about 250 bases. The 5' end of the gene was recovered using a 5'RACE kit (Cat. No. 18373-019) from Gibco BRL, and used according to the manufacturer's instructions, except for the substitution of Expand High Fidelity polymerase (Boehringer Mannheim, Indianapolis, IN) in place of Taq™ polymerase. The nucleotide sequence of the 5' and 3' clones was determined and combined to yield the complete sequence for the mature protease. The sequence of the wheat Dl protease gene is given in SEQ ID NO: 8 and the amino acid sequence of the encoded protein is given in SEQ ID NO:9. EXAMPLE 4 Cloning and sequencing of the Dl protease gene from Synechocystis 6803 Preparation of purified enzyme for amino acid sequencing Dl protease was biochemically isolated from Synechocystis 6803 as described above for Scenedesmus, Example 2, and the protein prepared for amino acid sequencing. Cloning of the Dl protease gene ctpB Degenerate primers were designed based on amino acid sequence data. The primers GG(TCG)GA(AG)GA(TC)TGGGT(GTC) SEQ ID NO: 10 and AT(AG)TA(AGC)CCNACNAC(AG)TT(TC)TC SEQ ID NO:l 1 were used to generate a 600 bp PCR fragment using 25 cycles of 1 min 93 °C, 1 min 55 °C and 30 sec 72 °C. The fragment was ligated into a pGEM-T vector (Promega, Madison, WI), according to the supplier's instructions. The resulting construct was used to generate a "ctpB" gene probe for use in Southern mapping. Mapping was accomplished by digesting total Synechocystis 6803 DNA with various combinations of restriction enzymes and then separating the digested DNA by gel electrophoresis. The DNA was blotted to membranes and probed with the above construct. Analysis of the mapping data indicated that digestion of Synechocystis 6803 DNA with Hindlll and Pstl would produce a 3.2 kb fragment containing the "ctpB" gene. An enriched gene bank was created by cutting the 3.2 kb region out of Hindlll-Pstl digested DNA run on an agarose gel, and ligating the recovered DNA fragments into Hindlll-Pstl cut pBluescript vector (Stratagene, Madison, WI). The resulting ligation products were transformed into E. coli and plated for single colonies. Colony lifts were probed with "ctpB" gene probe to identify colonies containing the gene. Positive colonies contained the 3.2 kb Hindlll-Pstl fragment which was sequenced and found to include the entire "ctpB" gene as well as a portion of the FtsZ gene. The sequence of the Synechocystis 6803 Dl protease gene is given in SEQ ID NO: 12 and the amino acid sequence of the encoded protein is given in SEQ ID NO: 13. EXAMPLE 5 Isolation And Sequencing of the Gene Encoding Tobacco Dl Protease A cDNA library was constructed from tobacco and was screened using a 770bp fragment of the wheat Dl protease gene. Screening of the library resulted in the isolation of a 1994 bp DNA fragment. The sequence of this fragment is given in SEQ ID NO: 14 and the encoded protein is given in SEQ ID NO: 15. Confirmation that this sequence encodes an active Dl protease was determined by heterologous expression in E. coli and enzyme assay of the gene product. EXAMPLE 6 Transformation of E. coli with the wheat Dl protease gene and expression of active Dl protease Vector construction and Expression PolyA mRNA was isolated from wheat as described above. cDNA was synthesized by using the materials and instructions provided in the Superscript Preamplification Kit (Life Technologies, Inc., Gaithersburg, MD). Gene specific primers were designed to prime at the 5' mature end and the 3' end of the gene. To these were added, respectively, Ncol and BamHI sites. CAG CCA TGG CGC TCA CGG AGGAGA AC (SEQ IDNO:16) Ncol 5' mature end ATA CTT GGG ATC CAT ATC ACG (SEQ ID NO: 17) Stop BamHI The "touchdown" PCR program (see above) consisted of 1 min at 94 °C, an annealing step of 1 min, and then 1 min at 72 °C. The temperature of the annealing step was progressively lowered starting at 60 °C for 1 min (for 3 cycles) and then lowered by 2 degrees every three cycles until 50 °C was reached whereupon 5 cycles were performed. The PCR product was cut with the restriction enzymes, Ncol and BamHI, from Promega (Madison, WI). This fragment was then subcloned into a pET expression vector (pET-32a(+) (Novagen Inc., Madison, WI) that encodes the protease fused to thioredoxin, and a linker containing an enterokinase proteolytic cleavage site. The expression vector was transformed into the E. coli non-expression host strain, NovaBlue (Novagen, Madison, WI) to obtain high plasmid yields. The transformed cells were plated out on LB agar. Ten colonies were selected and grown up in LB broth containing ampicillin (100 μg/mL) at 37 °C. The plasmid was purified according to the method described in the Wizard planned purification system (Promega, Madison, WI). The gene was sequenced in all ten plasmids to confirm the gene sequence and to check for the absence of PCR errors. The correct construct was then used to transform the tightly regulated E. coli host expression strain (BL21(DE3)pLysS) where expression is under the control of a T7 promotor. The transformed cells were grown at 37 °C to an optical density of 0.4 OD at 600 nm in LB broth and then induced with IPTG (1 mM) for three h. Transformed cells have now been grown in volumes as large as a 10 1 fermentor. Induction with IPTG produced inclusion bodies that amounted to -15% of the total cell protein and which were about 75% enriched in Dl protease. Purification and Enzyme activity: After induction, the cells were harvested by centrifugation and resuspended in 20 mM HEPES-NaOH buffer, pH 7.3, containing 0.1 % TRITON X-100, 0.1 mg/mL lysozyme, 5 mM MgCl 2 , 0.01 mg/mL RNAse and 0.05 mg/mL DNAse at room temperature. The suspension was spun down and the supernatant discarded. The pellet was resuspended in 20 mM HEPES-NaOH, pH 7.3, 1 mM EDTA, 0.1% TRITON X-100 and 0.3 M NaCl. The suspension was again spun down and the supernatant discarded. The pellet (90% enriched in the thioredoxin-Dl protease fusion) was resuspended in 20 mM HEPES-NaOH, pH 7.3, 1 mM EDTA and 5 mM DTT. All centrifugation steps were for 15 min at 12,000 rpm. The pellets were solubilized in 8 M guanidinium hydrochloride, 5 mM EDTA in 20 mM HEPES-NaOH, pH 7.3 at 1 mg protein/mL. The protein was refolded by 1:100 dilution into 20 mM MES, pH 6.0, 20 mM CHAPS, 10% glycerol, 1 M reduced glutathione, 1 mM oxidized glutathione. The concentrated protein was added either dropwise or with a peristaltic pump at a rate of 10 mL in 30-40 min to 1 liter of five additions were made with a one h interval between each addition for a total of 50 mg protein. The solution was then incubated overnight at 4 °C. The protein was then concentrated at 4 °C using a YM30 membrane in an Amicon concentration cell. The concentrated protein was then loaded onto a MonoQ (HRlO/10, Pharmacia,) column equilibrated with 15 mM CHAPS (3-[(3-cholamidopropyl)-dimethyl-ammonio]-l-propane sulfonate), 10% glycerol and 20 mM HEPES-NaOH, pH 7.3. The protein was eluted using a NaCl gradient from 0-400 mM in the same buffer. The fractions containing purified protease were then concentrated and further purified to homogeneity on a TSK4000 (G4000SW, 21.5 x 600 mm, TosoHaas) column with 15 mM CHAPS, 10% glycerol and 20 mM HEPES-NaOH, pH 7.3 as elution buffer. Cleavage of the N-terminal tags with enterokinase produces mature Dl protease with only three additional residues at its N-terminus. N-terminal cleavage increases about five-fold the specific activity of the protease. The enzymatic activity of the recombinant enzyme was assayed by using the microtiter plate ELISA assay with PSII core complexes from Scenedesmus LF-1 as substrate. The specific activity of the recombinant enzyme, expressed in relative units, is close to that of the natural enzyme isolated from wheat leaves. EXAMPLE 7 Synthesis of chloromethyl ketone inhibitors as potential Dl protease inhibitors. A variety of chloromethyl ketones were synthesized as potential Dl protease inhibitors. Abbreviations used in the following discussion of synthesis are listed below. LRMS: Low Resolution Mass Spectrometry HRMS: High Resolution Mass Spectrometry FAB: fast atom bombardment CI: chemical ionization Ala: L-alanine Leu: L-leucine Asp: L-aspartatic acid Boc: t-butoxy carbonyl Bzl: benzyl Z: benzyloxycarbonyl DCC: dicyclohexylcarbodiimide Su: succinimidyl THF: tetrahydrofuran DMF: dimethyl formaide Preparation of Boc-Ala-CH 2 Cl A. Generation of diazomethane In a 500 mL round bottom flask, connected with a 500 mL addition funnel, containing potassium hydroxide (12 g) in water (20 mL) was added diethyl ether (40 mL) and diethyleneglycol monoethyl ether (100 mL), then heated to 70 °C (oil bath). Diazald® (43 g) (Aldrich Chemical Co., Milwaukee, WI) in 400 mL of diethyl ether was poured into the addition funnel. As the diethyl ether started to distill, the Diazald® solution was added dropwise over a 30 min period. Ethanol (100 mL) was added to the addition funnel until the distillate became colorless. B. Preparation of Boc-Ala-CH 2 N ? Boc-Ala-OH (24.6, 130 mmol) was dissolved in THF (45 mL) and cooled to -20°C. The carboxyl group was activated by adding N-methylmorpholine (14.3 mL) and isobutyl chloroformate (17.0 mL) for 5-10 min. The resulting salt was filtered off and washed with 40 mL of cold THF. The freshly generated diazomethane was poured slowly into the filtrate at 0°C. The resulting mixture was warmed to room temperate after the nitrogen evolution finished. After 1 h stirring at room temp, the solvent was removed by rotavap to give Boc-Ala-CH 2 N 2 as bright solid of 28.9 g. C. Synthesis of Boc-Ala-CH 2 Cl To the crude Boc-Ala-CH 2 N 2 (28.9 g) in diethyl ether (200 mL) was added 5.0 N HC1 in dioxane (1 equiv., 28.5 mL) dropwise at 0°C. The solution turned colorless upon addition completion. The resulting solution was washed with cold water (200 mL), sat NaCl (aq) (150 mL x2), dried over Na 2 SO 4 . After filtration, the filtrate was concentrated to give crude product of 25.6 g. The crude solid was purified by flash silica gel column chromatography (20% hexane in ethyl acetate) and yielded pure Boc-Ala-CH 2 Cl of 20 g. LRMS(CI): m/e calculated for M (C 9 H 16 ClNO 3 ) + H: 222. Found: 222. Preparation of H-Asp(OfBu)-Leu-OH Z-Asp(OtBu)-OH (10.23 g) in THF (50 mL) was added N-methyl- morpholine (3.30 mL) and isobutyl chloroformate (3.90 mL) at -20 °C. After 10 min, the reaction mixture was added to the solution of H-Leu-OBzl (11.81 g in 50 mL HC1 3 ) at -20 °C, followed by addition of triethylamine (4.18 mL). The resulting mixture was allowed to warm to room temp. After filtering off the salt, the filtrate was concentrated to an oil. The oil was dissolved in 100 mL of ethyl acetate; washed with 0.2 N HC1, 5% NaHCO 3 and sat. NaCl; dried over Na 2 S0 4 . After filtration, the solvent was evaporated to give Z-Asp(OtBu)-Leu-OBzl as an oil of 14.81 g. The Z-Asp(OtBu)-Leu-OBzl (15.6 g) in methanol (50 mL) was added 10% Pd on carbon (0.17 g) and was hydrogenated on a Paar Shaker. After filtering off the catalyst, the filtrate was concentrated to give a foamy solid. The crude product was triturated with diethyl ether to yield 8.03 g of H-Asp(OtBu)-Leu-OH. LRMS(CI): m/e calculated for M (C 14 H 26 N 2 O 5 ) + H: 303. Found: 303. Preparation of Z-Leu-Asp(OtBu)-Leu-OH Z-Leu-OH (15.92 g) and N-hydroxysuccinimide (6.9 g) were dissolved in dioxane and cooled to 0 °C. To the cooled solution, DCC was added and stirred at 0 °C for 0.5 h, then room temp overnight. After filtering off the byproduct urea, the filtrate was concentrated to give crude Z-Leu-OSu as an oil. The H-Asp(OtBu)-Leu-OH (3.02 g), sodium bicarbonate (1.68 g), and 30 mL of water were mixed to give a mixture of pH 8. Z-Leu-OSu (3.63 g) in dioxane (30 mL) was added to the mixture and was stirred at room temp for 2 h. The reaction mixture was acidified by addition of cone. HC1 to pH 1.0, then was extracted with ethyl acetate (30 mL x 3). The combined extracts were dried over Na 2 SO 4 , filtered, and concentrated. The crude product was dissolved in methanol and chromatographed on a column of Sephadex™ LH20 to yield Z-Leu-Asp(OtBu)-Leu-OH as a foamy solid (4.43 g). LRMS(CI): m e calculated for M (C 28 H 43 N 3 0 8 ) + H: 550. Found: 550. Preparation of Z-Leu-Asp(OtBu)-Leu-Ala-CH2Cl Boc-Ala-CH2Cl (2 g) in 5 equiv of HC1 in dioxane was stirred at room temp for 1 h. After removal of solvent, the residue was triturated with diethyl ether to give crude H-Ala-CH 2 C1 (1.41 g). The Z-Leu-Asρ(OtBu)-Leu-OH (2.68 g) and N-methylmorpholine (0.54 mL) were dissolved in THF (25 mL), the cooled to -20 °C. Isobutyl chloroformate (0.64 mL) was added to generate the mixed anhydride, which was transferred to the H-Ala-C^Cl (1.41 g in 10 mL of DMF) solution at -20 °C. The resulting mixture was allowed to come to room temp and reaction was completed in 3 h. The salt was removed by filtration. The filtrate was concentrated, redissolved in ethyl acetate (100 mL). The solution was washed with 0.2 N HC1, 5% NaHCO 3 , sat. NaCl; dried over Na 2 SO 4 , filtered, and concentrated to yield crude solid of 3.19 g. The crude Z-Leu-Asp(OtBu)-Leu-Ala-CH 2 Cl was purified by Sephadex LH20 column chromatography. LRMS(FAB): m/e calculated for M (C 32 H 49 0 8 N 4 C1)+H: 653. Found: 653. HRMS(FAB): m e calculated for [M+H]: 653.3317. Found: 653.3283 Preparation of Z-Leu-Asp-Leu-Ala-C^Cl The Z-Leu-Asp(OtBu)-Leu-Ala-CH 2 Cl (0.653 g) in methylene chloride (5 mL) was stirred with trifluoroacetic acid (5 mL) at room temp for 2 h. After removal of the volatile species, the residue was triturated with diethyl ether to yield Z-Leu-Asp-Leu-Ala-CH 2 C1 as white powder (0.47 g). LRMS(FAB): m/e calculated for M (C 28 H 41 ClN 4 O8)+H: 597. Found: 597. HRMS(FAB): m/e calculated 597.2691 for [M+H]. Found: 597.2678. EXAMPLE 8 Microtiter plate assay of Dl Protease Preparation of primary antibody A synthetic peptide (EVMHERNAHNFPLDLA (SEQ ID NO: 18)) identical to the final 16 residues of practically all known sequences of polypeptide Dl [Satoh, (1993) in The Photosynthetic Reaction Center (Deisenhofer, J. and Norris, J. R., eds.) Vol. I, pp. 289-318, Academic Press, New York], was synthesized (>95% pure) and coupled to keyhole limpet hemocyanin (KLH) by using glutaraldehyde (Multiple Peptide Systems) at a 1 :1 ratio of peptide to KLH (w/w). New Zealand rabbits were immunized using the peptide-KLH conjugate suspended in PBS buffer (3.1 mg/mL) and emulsified by mixing with an equal volume of Freund's Adjuvant and injected into 5-6 subcutaneous dorsal sites for a total volume of 0.6 mL. The initial immunization was followed by three booster injections 21 d apart. The antiserum that was used as primary antibody in the assays was obtained from one rabbit 10 d after the second booster injection. The animals were bled from the ear vein, the blood heated at 37 °C for 1 h, chilled to 0 °C for 15 h and centrifuged. Further purification of the supernatant was not attempted. The serum was frozen and stored at -80 °C. Preparation of Microtiter Plates PSII core complexes were isolated from Scenedesmus wildtype and LF-1 as described by Diner et al, [J. Biol. Chem., 263, 8972-8980 (1988)] and stored at -80 °C. Immediately before use, they were diluted to 2 ng Chl/μL using TBS (20 mM Tris-HCl, pH 8.0, 150 mM NaCl). Each plate requires 5 μg Chi or 2.5 mL of diluted LF-1 cores and 0.2 μg Chi or 100 μL of WT cores. Ten plates were typically prepared at the same time. Glutaraldehyde (25% solution, EM grade, Electron Microscopy Sciences, Fort Washington, PA) was freshly opened from sealed ampoules and was diluted to 0.5% with TBS immediately before use (2.4 mL per plate). Twenty-five μL of the diluted glutaraldehyde were pipetted, using a Costar octapipette, into each well of a 96-well microtiter plate (Nunc Immunoplate Maxisorp, Cat. no. 439454). Twenty- five μL of the diluted LF-1 cores were pipetted per well into all but 3 wells of the plate (in column 12) and the plate shaken to mix the glutaraldehyde and the core complexes. Twenty-five μL of the diluted WT cores were pipetted per well into the remaining 3 wells and the plate again well-shaken to mix the glutaraldehyde and the core complexes. The plates were allowed to stand at room temperature for 1-2 h with continuous shaking at room temperature. The wells of column 12 are not incubated with protease and thereby show the maximum (WT wells) and minimum (LF-1 wells) signals attainable with the Dl protease assay. At the end of the incubation period, the wells were washed to remove unbound cores and blocked to prevent non-specific protein binding. Both were accomplished by giving each well 3 rinses with TTBS (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.2% Tween 20) and then filling each well with TTBS. The plates were then incubated for 1-2 h at room temperature, after which the wells were again rinsed. The remaining TTBS was aspirated and shaken out of the wells. The plates were then sealed in plastic bags containing a moistened paper towel. The plates were then stored in a -20 °C freezer and could be used over a period of months. It has been observed, however, that the background signal observed in blank wells lacking enzyme gradually increased with storage time. Assay of Enzyme Activity The samples to be assayed were diluted to 50 μL with 20 mM HEPES-KOH, pH 7.25, 20% glycerol (assay buffer) and placed in individual assay wells. Usually only rows B-G and columns 2-11 were used for assaying enzyme activity because the wells at the periphery of the plate often gave slightly higher signals. The wells containing the control WT and LF-1 cores in column 12 were also left empty. The samples of Dl protease were typically allowed to incubate for 1 h at room temperature after which each well was given 3 quick rinses with TTBS and then allowed to soak for 2 min. The TTBS was aspirated off and then refilled for another 2 min incubation. This was repeated two more times. The plate was then aspirated dry and turned over to tap any remaining buffer onto a paper towel. Five μL of primary antibody serum, directed against the final 16 residues of mature Dl polypeptide (Multiple Peptide Systems, see below), was diluted with 5 mL of PBS (1.44 g Na 2 HPO 4 , 0.24 g KH 2 PO 4 , pH 7.2, 8 g NaCl, 0.2 g KCl and 20 g bovine serum albumin per liter), previously filter sterilized through a 0.2 μm membrane. Fifty microliters of diluted secondary antibody solution were added to each well and the covered plates allowed to incubate on a rotary shaker at 37 °C. After 30 min, the plate was washed as above with the 3 cycles of soak and aspiration using TTBS. Ten μL of goat anti-rabbit conjugated to alkaline phosphatase (Sigma Immunochemicals A-7539) were diluted into 5 mL of TBS (3 g Tris-HCl, pH 8.0, 8 g NaCl, 0.2 g KCl and 20 g bovine serum albumin per liter) previously filter sterilized through a 0.2 μm membrane. Fifty microliters of diluted primary antibody solution were added to each well and the covered plates were allowed to incubate on a rotary shaker at 37 °C. After 30 min, the plate was washed as above with the 4 cycles of soak and aspiration using TTBS. The colorimetric substrate consisted of one 5 mg tablet of p-nitrophenyl phosphate (Kirkegaard & Perry Laboratories, 50-80-01) dissolved in 5 mL of 5x diluted DEA Buffer (Kirkegaard & Perry Laboratories, Gaithersburg, MD, 50-80-02). Fifty microliters of this solution were added to each well and the plate incubated at 37 °C in a microtiter plate reader (Molecular Devices, Thermomax) interfaced to a Macintosh SE/30. The time course of the increase in the concentration of p-nitrophenol was typically determined by monitoring the increase in absorption at 405 minus 650 nm for 10 min. Activity is expressed in terms of mOD/min. Alternatively, the plates were incubated at 37 °C for 1 h and measured by the same wavelength difference after quenching the reaction with 50 μL per of 3 M NaOH. The extent of cleavage of the Dl polypeptide in the test well could be determined by comparison with the control LF-1 and WT wells that had not been incubated with enzyme. The ratio of the signals from these wells were usually 1:15-30, respectively, indicating that the primary antibody directed against the mature C-terminus has a much reduced affinity for the preprocessed C-terminus of the Dl polypeptide. An example of the dependence of the assay on enzyme concentration is shown in Figure 1 where the intensity of the color reaction is shown to be proportional to enzyme concentration up to approximately 20% of pre-Dl cleaved. Figure 1 is a plot of Scenedesmus Dl protease enzyme activity versus enzyme concentration. Purified enzyme was diluted with assay buffer (20 mM HEPES-KOH, pH 7.25, 20% glycerol) at the indicated relative concentrations and incubated in the microtiter plate wells for 1 h at room temperature. The most concentrated enzyme solution used was approximately 13 nM. At 50 μL/well this is equivalent to 650 finoles enzyme/well. The ordinate is expressed as the percentage of the signal obtained with a concentration of wildtype PSII cores equal to those of LF-1. One hundred percent corresponds to fully processed cores. As shown in Figure 2, the assay is also linear with time up to approximately the same percentage of cleaved pre-D 1. The optimum pH is 6.3 ± 0.3. As shown in Figure 2, purified enzyme was diluted to a concentration of 810 pM or 40 finoles per well (50 μL) with assay buffer. The enzyme incubated was in the microtiter plate wells at room temperature for the indicated times. The ordinate is expressed as the percentage of the signal obtained with a concentration of wildtype PSII cores equal to those of LF-1. One hundred percent corresponds to fully processed cores. EXAMPLE 9 In vitro high-throughput screening assay using thylakoid membrane fragments containing pre-Dl and wheat Dl protease Example 9 demonstrates an in vitro assay for Dl protease. The assay resulted in the generation of 2 different enzyme products consisting of a mature Dl protein and a C-terminal tail portion of the pre-protein. The assay was capable of detecting both type of products. Because this assay used isolated thylakoid membrane containing the Dl pre-protein substrate the assay could be run at a pH similar to that found in the whole plant. DETECTING THE MATURE Dl ENZYME PRODUCT Source of Substrate and Dl Protease The PSII-enriched thylakoid membrane fragment was isolated from Scenedesmus LF-1 mutant cells using a mild TRITON X-100-treatment as follows: Scenedesmus cells were broken in a "bead-beater" (Biospec Products, Bartlesville, OK) in an ice- water bath with 1-mm diameter glass beads using 10 bursts of 45 sec each. The thylakoid membranes were separated from the homogenate using centrifugation, and then the PSII-enriched thylakoid membrane fragment was isolated using TRITON X-100-treatment (TRITON hlorophyll = 15-20:1) and centrifugation according to the procedure described by Miyao et al., [(1991J Biochim. Biophys. Acta 1056, 47-56]. The thylakoid membrane fragments contain the unprocessed Dl polypeptide. Wheat Dl -protease was purified from wheat leaves as described in the GENERAL METHODS. Preparation of Assay Plates The assay made use of a 96-well format multiscreen assay system made by Millipore Corporation (Bedford, MA, OF1730; cat No. MADV NOB). Each well of the 96-well microtiter plate contained a low-protein-binding Durapore membrane (pore size = 0.65 mm). Wells were pre-wet with TBSM (TBS buffer plus 5 mM MgCy, and then the TBSM solution was removed by drawing the liquid through the membrane using the MultiScreen assay system with its vacuum manifold and pump, according to the manufacturer's instructions. All washes and rinses were performed in a similar manner. Wells were then blocked with the blocking reagent for 5 min as recommended by the manufacturer and the blocking solution was removed by applying vacuum. Enzyme assay and signal detection A 20-50 μL reaction mixture was added to each well consisting of LF-1 thylakoid membrane, (final PSII reaction center concentration to 0.25 mM) and wheat Dl -protease (final enzyme concentration:200 pM) in reaction buffer (20 mM Mes-NaOH, pH 5.2, 5 mM MgCl 2 and 5 mM MnCl 2 ). Plates were incubated for 15 min at room temperature with shaking at which time the reaction liquid was removed and the plate was washed once with TBSM. At this stage, only the thylakoid membrane was left in the well because of the presence of MgC^. The thylakoid membrane will stack together (as in vivo), and the stacked thylakoid membranes are too large to pass through the plate membrane pore. Two types of primary antibodies were used. Type 1 was a primary antibody prepared as described in Example 8, containing no reporter. Type 2 affinity purified primary antibody was conjugated to the reporting enzyme Horseradish peroxidase (HRP)(Sigma Chemical Co., St. Louis, MO) Both type 1 and type 2 antibodies recognized the mature Dl C-terminus. Either type 1 or type 2 primary antibody was added into each well, and plates were incubated at 37 °C for 10 min. In assays using type 1 antibody, anti- rabbit IgG alkaline phosphatase conjugate was added to each well and plates were allowed to incubate again at 37 °C for additional 20 min. After this, incubation plates were washed with TBSM to remove the unbound antibodies. When using type 2 antibody for the assay, no secondary antibody was added, and the plate was directly washed after primary antibody incubation. When using the unlabeled type 1 primary antibody, plus secondary antibody, 50 uL of the colorimetric substrate, p-nitrophenyl phosphate, or fluorescent substrate, Atto-phos (JBL Scientific Inc., San Luispo, CA), was added to each well, and plates were incubated for 10-30 min. During the transfer process, the substrate (p-nitrophenyl phosphate or Atto-phos) was separated from the alkaline phosphatase, stopping the reaction automatically. When using the type 2 HRP conjugated primary antibody 50 mL of colorimetric substrate, TMB (Kirkgaard & Perry Laboratories, Inc., Gaithersburg, MD) or fluorescent substrate, N-acetyl-3,7-dihydroxyphenoxazine (A6550, Molecular Probes, Inc., Eugene, OR) or chemiluminescence substrate, BM Chemiluminescence ELISA Reagent (Boehringer Mannheim Corp., Indianapolis, IN) was added to each well. Plates were incubated for 15 min. Next the substrate was transfered to a regular plastic 96-well microtiter plate using the manifold and vacuum and then read for absorption or fluorescence or chmiluminescence intensity. In the case of fluorescence and chemiluminescence detection, the signal can be directly detected without a filtration step. Measurements can be made in end point or kinetic mode. Finally, plates were read on a microtiter plate reader, measuring the change in fluorescence or absorption. Control wells included all the same reagents as the experimental with the exception of Dl protease enzyme. TABLE 4 Without DIP With DIP Typel AB and PNP (Absorbance OD 450-650) 0.06 OD 0.365 OD Typel AB and ATTOPHOS (Fluorescence intensity) 414 RU 1070 RU Type2 AB and TMB (Absorbance at OD 650-450) 0.023 OD 0.141 OD Type2 AB and TMB and 7 mM of Z-LDLA-CMK*, ++ (Absorption change) 0.023 OD 0.081 OD Type 2 AB and A6550 (Fluorescence intensity) 134 RU 263 RU Type2 AB and BM (Chemiluminescence intensity) 16 RU 33 RU * Dl protease has been pre-incubated with Z-LDLA-CMK for 1 h at pH 7.0 ++ Z-LDLA-CMK is synthesized as described in Example 7. DETECTING FREE C-TERMINAL Dl-TAIL ENZYME PRODUCT Source of Substrate and Dl Protease As above, LF-1 thylakoid membranes were isolated and used as enzyme substrate. The source of enzyme was recombinant or native purified Wheat Dl -protease. Molecular Probes Fluorescamine (Molecular Probe Inc., Eugene, OR) is a molecular probe capable of detecting compounds containing primary amines and were used in this assay method. This probe has the ability to react with N-terinal amines formed on the C-terminal Dl-tail portion of the Dl pre-protein, produced as a result of Dl protease action on the substrate. Assay Method Assays were run in a 96-well multiscreen plate and prepared as described above. After incubation with Dl protease the reaction mixture containing the C-terminal Dl-tail fragment was transferred to a regular plastic 96-well microtiter plate using a vacuum manifold and pump. The small (approx. size of tail is 1-2 kDa) Dl-tail fragment passes through the Durapore® membrane (pore size = 0.65 mm) leaving the stacked thyalkoid membranes in the well. 150 mL sodium phosphate buffer (50 mM, pH 8.0) and 50 mL of 1.08 mM fluorescamine in acetone were added to each well and the plate was shaken for 1 min at room temperature. After incubation fluorescence was read on a microtiter plate reader at 400 nm excitation, 460 nm emission. TABLE 5 Well with D 1 protease 515 ± 10 relative units Well without Dl protease 470 ± 10 relative units EXAMPLE 10 In vivo high throughput incorporating Scenedesmus mutant and wildtype cells for the detection of a Dl protease inhibitor • Example 10 demonstrates an in vivo assay whole cell system to screen for herbicidal agents that target Dl protease. The specific herbicidal agent identified in this example is a known protease inhibitor which comprises a peptide component and will be refered to as IHN-1. The assay system utilized mutant and wildtype Scenedesmus cells in a reaction mixture that contained a potential Dl protease inhibitor. LF-1 Scenedesmus mutants contain an inactivated Dl protease and are unable to process pre-Dl to the mature protein. Wildtype Scenedesmus contain a functional Dl protease and Dl pre-protein is processed normally. Therefore, in LF-1 cells 100% of Dl protease activity is inhibited. The LF-1 cell shows weaker Fv than that of the wildtype cell [Metz et al., (1980) Biochem. Biophys. Res. Comm. 94, 560 566] upon illumination at high light intensity (10-100 photons per sec per center). Furthermore, it has been shown that the Fi of LF-1 cell is 2-3 fold higher than that of the wildtype cell. When Scenedesmus wildtype cells are illuminated in a suitable growth medium containing a Dl protease inhibitor, Fi-increases and an Fv-decreases. Assay Method Wildtype and LF-1 mutant cells were suspended in BG-11 liquid growth medium and placed in 96-well plates, and the cell concentration was adjusted to OD 3 o = 2-3. Dl -protease inhibitor was added to each well and both Fo and Fv fluorescence was measured immediately, using a fluorescence microtiter plate reader. Plates were then placed under strong illumination (200 μ Einsteins.m^.s - 1 ) for 1-3 h, and the fluorescence was measured again. The presence of Dl protease inhibitor is confirmed by an Fi-increase and Fv-decrease in the wildtype cells. No change is observed for LF-1 cells (either with or without inhibitor) after the incubation. The wildtype cells without the addition of inhibitor are used as a 0% inhibition control; and the LF-1 cells are used for 100% inhibition control. Table 6 shows the relative change in Fo and Fv in incubations of mutant and wildtype cells both with and without a Dl protease inhibitor screened in an in vitro assay. As can be seen by the data in Table 6 there is no Fo and Fv change for (LF-l+IHN-1), even after a 3 h incubation. TABLE 6 Time Fi-(vvt) Fv-(wt) Fi-(LFl) Fv-(LFl) Fi-(wt+INH-l) Fv-(wt+INH-l) O h 20 30 45 24 20 30 3 h 21 32 45 24 25 29 * Fi measurement: excitation, 360 nm/40 nm band width; emission,665 nm/20 nm band width; Gain, 80; regul ar fiber optic bundle * Fv measurement: excitation, 450 nm/50 nm band width; emission, 665 nm/2C ) nm band width; Gain, 33; visible fiber optic bundle SEQUENCE LI STING (1) GENERAL INFORMATION: (i) APPLICANT: (A) ADDRESSEE: E.I. DU PONT DE NEMOURS AND COMPANY (B) STREET: 1007 MARKET STREET (C) CITY: WILMINGTON (D) STATE: DELAWARE (E) COUNTRY: U.S.A. (F) ZIP: 19898 (G) TELEPHONE: 302-892-8112 (H) TELEFAX: 302-773-0164 (I) TELEX: 6717325 (ii) TITLE OF INVENTION: METHODS FOR IDENTIFYING HERBICIDAL AGENTS THAT INHIBIT Dl PROTEASE (iii) NUMBER OF SEQUENCES: 29 (iv) COMPUTER READABLE FORM: (A) MEDIUM TYPE: DISKETTE, 3.50 INCH (B) COMPUTER: IBM PC COMPATIBLE (C) OPERATING SYSTEM: MICROSOFT WINDOWS 95 (D) SOFTWARE: MICROSOFT WORD VERSION 7.0A (v) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: (B) FILING DATE: (C) CLASSIFICATION: (vi) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: 08/759,581 (B) FILING DATE: DECEMBER 5, 1996 (vii) ATTORNEY/AGENT INFORMATION: (A) NAME: FLOYD, LINDA AXAMETHY (B) REGISTRATION NO. : 33,692 (C) REFERENCE/DOCKET NUMBER: CR-9964-A (2) INFORMATION FOR SEQ ID N0:1: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear ( i) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: PRIMER A (xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: GAAGGCTGGC AGGCGTGA 18 (2) INFORMATION FOR SEQ ID NO:2: ( ) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: PRIMER B (xi ) SEQUENCE DESCRIPTION: SEQ ID NO: 2: CCAGTCGCGC ATAGTAAGTA TACTC 25 (2) INFORMATION FOR SEQ ID NO:3: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1680 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: SCENEDESMUS GENE (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: GGGGTACTCC CGGACAAACT GCTTGCAAAC CAGCGTCCGA GCACCGCAAC CACACTTCAG 60 GCCATTTACT GCAGTCAAAA CATGTAGACA GCGGTGCAGC ACAACTGCAG CAGCAGCCAA 120 GCGTGATCAG GCGCAAGAAC AGCAGCCATG GATTCAGGTT GGGCTGGGCC TGGCAGCTGC 180 TGCCACTGCA GTGGCAGTGG GCCTGGGGGC AGCTGCGCTG CCGGCGCAAG CAGTGACAAG 240 CGAGCAGCTG CTGTTCCTGG AAGCATGGCG AGCAGTGGAC AGGGCTTATG TGGACAAATC 300 GTTCAACGGG CAGAGCTGGT TCAAGCTACG GGAGACGTAC CTTAAGAAGG AGCCCATGGA 360 CAGGCGGGCG CAGACATATG ATGCCATCCG CAAGCTGCTG GCGGTGCTGG ACGACCCCTT 420 CACGCGCTTC TTGGAGCCCT CACGCCTGGC TGCGCTGCGG CGAGGCACAG CAGGCTCTGT 480 TACAGGTGTA GGCTTGGAGA TAACGTATGA CGGCGGCAGC GGCAAAGACG TTGTAGTGCT 540 GACGCCTGCG CCTGGCGGGC CGGCAGAGAA GGCTGGTGCA CGGGCTGGTG ATGTCATTGT 600 GACAGTGGAT GGCACGGCTG TGAAGGGGCT GTCGCTGTAT GACGTGTCTG ATTTGCTGCA 660 AGGAGAGGCT GACTCACAGG TGGAGGTGGT GCTGCATGCG CCTGGAGCAC CCAGCAACAC 720 GCGCACGCTG CAGCTGACGC GCCAGAAAGT GACCATCAAC CCAGTCACGT TCACCACCTG 780 CAGCAACGTG GCAGCAGCAG CACTGCCTCC AGGTGCCGCG AAGCAGCAGC TGGGCTATGT 840 GCGGCTGGCC ACCTTCAACA GCAACACCAC AGCAGCAGCA CAGCAGGCGT TCACAGAGCT 900 GAGCAAGCAG GGCGTGGCTG GCTTGGTGCT GGACATACGC AACAACGGCG GCGGCCTGTT 960 CCCAGCAGGT GTGAACGTGG CGCGCATGCT GGTGGACCGG GGTGATTTGG TGCTCATCGC 1020 GGACAGCCAG GGCATCCGTG ACATCTACTC GGCTGACGGC AACAGCATCG ACAGTGCCAC 1080 GCCGCTGGTG GTGCTGGTCA ACAGGGGCAC AGCCTCCGCC TCAGAGGTGC TTGCTGGCGC 1140 GCTGAAGGAC AGCAAGCGGG GCCTCATAGC TGGCGAGCGC ACCTTTGGCA AGGGCCTCAT 1200 TCAGACTGTG GTGGACTTGT CGGATGGCTC TGGCGTGGCT GTGACGGTTG CGCGGTACCA 1260 GACGCCAGCT GGCGTTGACA TCAACAAGAT AGGTGTCAGT CCAGATGTGC AGCTTGACCC 1320 AGAGGTGCTG CCGACAGATC TGGAGGGGGT GTGCCGCGTG CTGGGGTCTG ATGCTGCGCC 1380 GCGGCTGTTT GGGTGAGCTG TCACAGCAGT GTGTGGCTGC AGGGTGTGTT CGTGCGCGGG 1440 GGCGCACACG GCACTGCAAG CGTTTGTAGG GCAACCGGCA CTCGAGCAGC GTTGTGACAG 1500 CACGCGTCGT TGTCAGCTCG TGTGAGCATC AGCAACCCCG GACAACAAGC AGCAGCAGCA 1560 CTCGGGCGTG CGTGTCCCTG CACGGTCAGC TGCACACAGT TGGCGCGATG GATTTGCTTG 1620 TCATTGCTTG CTGGCTGTCG TGGAACGTGG ACCTGCATAC ATATCACCTT GAAATGATCA 1680 (2) INFORMATION FOR SEQ ID NO: 4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 387 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (vi) ORIGINAL SOURCE: (B) STRAIN: SCENEDESMUS Dl PROTEASE PROTEIN (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4: Val Thr Ser Glu Gin Leu Leu Phe Leu Glu Ala Trp Arg Ala Val Asp 1 5 10 15 Arg Ala Tyr Val Asp Lys Ser Phe Asn Gly Gin Ser Trp Phe Lys Leu 20 25 30 Arg Glu Thr Tyr Leu Lys Lys Glu Pro Met Asp Arg Arg Ala Gin Thr 35 40 45 Tyr Asp Ala lie Arg Lys Leu Leu Ala Val Leu Asp Asp Pro Phe Thr 50 55 60 Arg Phe Leu Glu Pro Ser Arg Leu Ala Ala Leu Arg Arg Gly Thr Ala 65 70 75 80 Gly Ser Val Thr Gly Val Gly Leu Glu lie Thr Tyr Asp Gly Gly Ser 85 90 95 Gly Lys Asp Val Val Val Leu Thr Pro Ala Pro Gly Gly Pro Ala Glu 100 105 110 Lys Ala Gly Ala Arg Ala Gly Asp Val lie Val Thr Val Asp Gly Thr 115 120 125 Ala Val Lys Gly Leu Ser Leu Tyr Asp Val Ser Asp Leu Leu Gin Gly 130 135 140 Glu Ala Asp Ser Gin Val Glu Val Val Leu His Ala Pro Gly Ala Pro 145 150 155 160 Ser Asn Thr Arg Thr Leu Gin Leu Thr Arg Gin Lys Val Thr lie Asn 165 170 175 Pro Val Thr Phe Thr Thr Cys Ser Asn Val Ala Ala Ala Ala Leu Pro 180 185 190 Pro Gly Ala Ala Lys Gin Gin Leu Gly Tyr Val Arg Leu Ala Thr Phe 195 200 205 Asn Ser Asn Thr Thr Ala Ala Ala Gin Gin Ala Phe Thr Glu Leu Ser 210 215 220 Lys Gin Gly Val Ala Gly Leu Val Leu Asp lie Arg Asn Asn Gly Gly 225 230 235 240 Gly Leu Phe Pro Ala Gly Val Asn Val Ala Arg Met Leu Val Asp Arg 245 250 255 Gly Asp Leu Val Leu lie Ala Asp Ser Gin Gly lie Arg Asp lie Tyr 260 265 270 Ser Ala Asp Gly Asn Ser lie Asp Ser Ala Thr Pro Leu Val Val Leu 275 280 285 Val Asn Arg Gly Thr Ala Ser Ala Ser Glu Val Leu Ala Gly Ala Leu 290 295 300 Lys Asp Ser Lys Arg Gly Leu lie Ala Gly Glu Arg Thr Phe Gly Lys 305 310 315 320 Gly Leu He Gin Thr Val Val Asp Leu Ser Asp Gly Ser Gly Val Ala 325 330 335 Val Thr Val Ala Arg Tyr Gin Thr Pro Ala Gly Val Asp He Asn Lys 340 345 350 He Gly Val Ser Pro Asp Val Gin Leu Asp Pro Glu Val Leu Pro Thr 355 360 365 Asp Leu Glu Gly Val Cys Arg Val Leu Gly Ser Asp Ala Ala Pro Arg 370 375 380 Leu Phe Gly 385 (2) INFORMATION FOR SEQ ID NO: 5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 5 : ATGGACTATC TTACTGACTG C 21 (2) INFORMATION FOR SEQ ID NO: 6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6: GCTGAATCTT CGAATTGCCC CTTC 24 (2) INFORMATION FOR SEQ ID NO: : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 29 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7: TCTGAACCTG GAATCTCACA CATCCTTGA 29 (2) INFORMATION FOR SEQ ID NO: 8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1164 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: WHEAT Dl PROTEASE GENE (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8: CTCACGGAGG AGAACCTGCT GTTCCTGGAG GCGTGGCGCG CGGTGGACCG CGCCTACTAC 60 GACAAGTCCT TCAACGGGCA GAGCTGGTTC AGGTACCGCG AGCGCGCCCT CCGCGACGAC 120 CCCATGAACA CGCGGCAGGA GACATATGCG GCGATTAAGA AAATGCTTGC AACCTTGGAT 180 GATCCGTTCA CTCGGTTATT GGAACCCGAG AAATTCAAGA GTTTGCGGTC TGGCACGCAA 240 GGTGCCCTCA CGGGTGTAGG TTTATCCATC GGCTACCCGT TGGCCCTTAA AGGATCACCT 300 GCAGGGCTCT CCGTAATGTC AGCAGCCCCA GGGGGTCCTG CAGAAAAGGC GGGCATTGTG 360 TCTGGAGACG TTATTTTGGC AATTGACGAC ACAAGCGCAC AAGACATGGA CATATATGAC 420 GCAGCAGATC GCTTACAGGG TCCTGAAGGA AGCTCAATAG ATTTGACTAT TCTCAGTGGA 480 GCTGATACCA GACATGTTGT TTTGAAGCGA GAAAGATATA CTTTAAACCC GGTGAGGTCA 540 AGGATGTGTG AGATTCCAGG TTCAGAGGAT AGCTCAAAGA TTGGTTACAT CAAACTAACA 600 ACATTTAACC AAAATGCTGC AGGGTCTGTT AAGGAAGCCA TTAAGAAATT AAGGGAGAAA 660 AACGTAAAGG CCTTTGTGTT GGATCTGCGG AATAACAGCG GTGGTCTTTT TCCCGAAGGG 720 ATTGAGATTG CGAAGATTTG GATGGACAAG GGTGTCATTG TGTATATATG TGATAGCCGT 780 GGTGTCCGTG ACATTTATGA GGCAGATGGA GCTAGCACGA TTGCTGCATC AGAACCTTTA 840 GTTGTCCTGG TAAACAAAGG AACCGCAAGT GCAAGTGAGA TCCTTGCAGG AGCACTGAAA 900 GACAACAAGA GGGCAGTGGT GTATGGGGAA CCAACATATG GAAAAGGCAA GATCCAGTCG 960 GTGTTTGCAC TGTCCGATGG CTCAGGGTTG GCCGTGACGG TGGCGCGCTA CGAAACCCCT 1020 GCGCATACTG ACATAGATAA GGTCGGTGTG ACTCCGGACC GTCCATTGCC GGCATCATTC 1080 CCGACCGACG AGGATGGCTT CTGCAGCTGC CTCAGGGACC CAGCTTCTTG CAACCTTAAT 1140 GCTGCCCGGC TGTTTGTGAG ATCG 1164 (2) INFORMATION FOR SEQ ID NO: 9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 388 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (vi) ORIGINAL SOURCE: (B) STRAIN: WHEAT Dl PROTEASE PROTEIN (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9: Leu Thr Glu Glu Asn Leu Leu Phe Leu Glu Ala Trp Arg Ala Val Asp 1 5 10 15 Arg Ala Tyr Tyr Asp Lys Ser Phe Asn Gly Gin Ser Trp Phe Arg Tyr 20 25 30 Arg Glu Arg Ala Leu Arg Asp Asp Pro Met Asn Thr Arg Gin Glu Thr 35 40 45 Tyr Ala Ala He Lys Lys Met Leu Ala Thr Leu Asp Asp Pro Phe Thr 50 55 60 Arg Leu Leu Glu Pro Glu Lys Phe Lys Ser Leu Arg Ser Gly Thr Gin 65 70 75 80 Gly Ala Leu Thr Gly Val Gly Leu Ser He Gly Tyr Pro Leu Ala Leu 85 90 95 Lys Gly Ser Pro Ala Gly Leu Ser Val Met Ser Ala Ala Pro Gly Gly 100 105 110 Pro Ala Glu Lys Ala Gly He Val Ser Gly Asp Val He Leu Ala He 115 120 125 Asp Asp Thr Ser Ala Gin Asp Met Asp He Tyr Asp Ala Ala Asp Arg 130 135 140 Leu Gin Gly Pro Glu Gly Ser Ser He Asp Leu Thr He Leu Ser Gly 145 150 155 160 Ala Asp Thr Arg His Val Val Leu Lys Arg Glu Arg Tyr Thr Leu Asn 165 170 175 Pro Val Arg Ser Arg Met Cys Glu He Pro Gly Ser Glu Asp Ser Ser 180 185 190 Lys He Gly Tyr He Lys Leu Thr Thr Phe Asn Gin Asn Ala Ala Gly 195 200 205 Ser Val Lys Glu Ala He Lys Lys Leu Arg Glu Lys Asn Val Lys Ala 210 215 220 Phe Val Leu Asp Leu Arg Asn Asn Ser Gly Gly Leu Phe Pro Glu Gly 225 230 235 240 He Glu He Ala Lys He Trp Met Asp Lys Gly Val He Val Tyr He 245 250 ■ 255 Cys Asp Ser Arg Gly Val. Arg Asp He Tyr Glu Ala Asp Gly Ala Ser 260 265 270 Thr He Ala Ala Ser Glu Pro Leu Val Val Leu Val Asn Lys Gly Thr 275 280 285 Ala Ser Ala Ser Glu He Leu Ala Gly Ala Leu Lys Asp Asn Lys Arg 290 295 300 Ala Val Val Tyr Gly Glu Pro Thr Tyr Gly Lys Gly Lys He Gin Ser 305 310 315 320 Val Phe Ala Leu Ser Asp Gly Ser Gly Leu Ala Val Thr Val Ala Arg 325 330 335 Tyr Glu Thr Pro Ala His Thr Asp He Asp Lys Val Gly Val Thr Pro 340 345 350 Asp Arg Pro Leu Pro Ala Ser Phe Pro Thr Asp Glu Asp Gly Phe Cys 355 360 365 Ser Cys Leu Arg Asp Pro Ala Ser Cys Asn Leu Asn Ala Ala Arg Leu 370 375 380 Phe Val Arg Ser 385 (2) INFORMATION FOR SEQ ID NO: 10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10: GGTCGGAAGG ATCTGGGTGT C 21 (2) INFORMATION FOR SEQ ID NO:H: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11: ATAGTAAGCC CACACAGTTT CTC 23 (2) INFORMATION FOR SEQ ID NO: 12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1485 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: SYNECHOCYSTIS Dl PROTEASE GENE (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 12: ACCTAGTAGT CAAGGACTCT AAGCACCGCC CCGGGGTTTA TTTTCTTAAC TAATCTTCTT 60 CAACGGTCCG GTAAATCTCA TGTTGAAGCA AAAGCGCAGT CTAATTTTGG GAACTACAGC 120 TCTGTTATTG ACAACAGTGG CGGTGACGGG GGTTGGGTTG CGATTGGCCC GCTCCCAGGG 180 CTACCTACAG GATAATCTCA AGGAGCTGGT TGACGAAGTT TGGCAAATTG TCGACCACAC 240 CTATGTAGAT GGTACTTTCA ACGGTGAGGA TTGGGTAGCG GTTCGCCAGG ATTATCTAAC 300 ACGGGACTAC AAAAACCAGG AAGAAGCCTA CACCGCCATT CGGGAAATGC TGGAGAAGCT 360 AAATGACCCC TACACTCGCT TCATGTCCCC CGATGAGTTT CAATCAATGC GTATCGACAC 420 TTCCGGTGAA TTGACCGGGG TGGGTATTCA AATCACCCAG GACCAGGATA CGAAGAAAAT 480 TGTGGTGGTG GCTCCCATCG AAGATACCCC CGCCTACAAC GCTGGCATTC TTTCTAAGGA 540 CATAATTACC AAGATTGACG GTAAGTCCAC CGATGGCATG GAAGTAGATG ACGCAGTGAA 600 GTTAATTCGG GGTAAGCCCG GCACCAGTGT GGCGCTCACT ATTGAGCGGG AAGGGCAGGC 660 GATCGAATAT CCTTTGACCC GGACTTTAAT TAAAATTCAT CCAGTGCGGG CCCAAGTGGA 720 AGATATTAAT GGTGCCAGGG TTGGTTATAT CCGTTTAAAT CAATCCAGTG CCCAGGCTTC 780 GGAGGAAATG CGCCAAGCAG TGCAGAAATT GAAAAAAGAG AATGTGGTCG GCTACATTTT 840 TGACCTGCGT TCCAATCCCG GTGGTTTGAT CTATCCCAGT GCGAATATCG CTCGCATTTG 900 GTTGGATGAA GGGGGCATTG TGTCCACCGT CGATCGCCGA GGGGAAGTGG AACAACAAAG 960 TGCTAACAAG CGACAGTCGA GTAACCGTCC CCTAGTGGCG TCGACGAATG GCGGTTCCGC 1020 CAGCGCCAAT AAAATCATCT CCGGGGCCTT ACAGAATAAT CAACGGGCCG TCATCGTGGG 1080 CACCAAAACC TTTGATAAGG AATTAGTACA ATCGGTGCGG GAGTTGGGGG ATGGTTCCGG 1140 TATGGCAGTG ACGATCGCCA AATATTTAAT CCCCAACGGT CGGGACATCA ATAAACATGG 1200 CATCGACCCC TATGTGGAAG TAGAACTCAC CGACGCCCAG CGGAAGGAAT TGCAACAAAA 1260 TCGGGAAAAA GTAGGCACCC TGGAAGACCC CCAATTTGCC AGGGCCTATG AAGTGCTAAT 1320 GCAACAGGTG AACAAAACCG CTTCTAAGTA GCTTAAGTAG GTTGAACGAG CTTGTACAAT 1380 TTCATTCGGT AAAAGTCTAT GGTTCAAACT GCCCTACTTC CCCTCGACTT TCCCGATCTA 1440 TATCCGGAAT CCGACGGTAA ACCCATGGCT GACAATACCC TGCAG 1485 (2) INFORMATION FOR SEQ ID NO: 13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 391 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (vi) ORIGINAL SOURCE: (B) STRAIN: SYNECHOCYSTIS Dl PROTEASE PROTEIN (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13: Gin Gly Tyr Leu Gin Asp Asn Pro Lys Glu Leu Val Asp Glu Val Trp 1 5 10 15 Gin He Val Asn Arg Thr Tyr Val Asp Gly Thr Phe Asn Gly Glu Asp 20 25 30 Trp Val Ala Val Arg Gin Asp Tyr Leu Thr Arg Asp Tyr Lys Asn Gin 35 40 45 Glu Glu Ala Tyr Thr Ala He Arg Glu Met Leu Glu Lys Leu Asn Asp 50 55 60 Pro Tyr Thr Arg Phe Met Ser Pro Asp Glu Phe Gin Ser Met Arg He 65 70 75 80 Asp Thr Ser Gly Glu Leu Thr Gly Val Gly He Gin He Thr Gin Asp 85 90 95 Gin Asp Thr Lys Lys He Val Val Val Ala Pro He Glu Asp Thr Pro 100 105 110 Ala Tyr Asn Ala Gly He Leu Ser Lys Asp He He Thr Lys He Asp 115 120 125 Gly Lys Ser Thr Asp Gly Met Glu Val Asp Asp Ala Val Lys Leu He 130 135 140 Arg Gly Lys Pro Gly Thr Ser Val Ala Leu Thr He Glu Arg Glu Gly 145 150 155 160 Gin Ala He Glu Tyr Pro Leu Thr Arg Thr Leu He Glu He His Pro 165 170 175 Val Arg Ala Gin Val Glu Asp He Asn Gly Ala Arg Val Gly Tyr He 180 185 190 Arg Leu Asn Gin Phe Ser Ala Gin Ala Ser Glu Glu Met Arg Gin Ala 195 200 205 Val Gin Lys Leu Glu Lys Glu Asn Val Val Gly Tyr He Phe Asp Leu 210 215 220 Arg Ser Asn Pro Gly Gly Leu Leu Tyr Ser Ser Val Asp He Ala Arg 225 230 235 240 He Trp Leu Asp Glu Gly Gly He Val Ser Thr Val Asp Arg Arg Gly 245 250 255 Glu Val Glu Gin Gin Ser Ala Asn Lys Arg Gin Leu Ser Asn Arg Pro 260 265 270 Leu Val Val Leu Val Asp Gly Gly Ser Pro Ser Ala Ser Glu He Val 275 280 285 Ser Gly Ala Leu Gin Asp Asn Gin Arg Ala Val He Val Gly Thr Lys 290 295 300 Thr Phe Gly Lys Gly Leu Val Gin Ser Val Arg Glu Leu Gly Asp Gly 305 310 315 320 Ser Gly Met Ala Val Thr He Ala Lys Tyr Leu Thr Pro Asn Gly Arg 325 330 335 Asp He Asn Lys His Gly He Asp Pro Asp Val Glu Val Glu Leu Thr 340 345 350 Asp Ala Gin Arg Lys Glu Leu Gin Gin Asn Arg Glu Lys Val Gly Thr 355 360 365 Leu Glu Asp Pro Gin Phe Ala Arg Ala Tyr Glu Val Leu Met Gin Gin 370 375 380 Val Asn Lys Thr Ala Ser Lys 385 390 (2) INFORMATION FOR SEQ ID NO: 14: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1994 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: TOBACCO Dl PROTEASE GENE (xi ) SEQUENCE DESCRIPTION: SEQ ID NO: 14: AGGAATTCGG CACGAGACTA GAAAAAGGGG ATAAGAGAAG GAAAAAAAAG AAAGAAGCAA 60 AACGATAACA AACAGAATTG AAAACGAAAT TGAGCAATGG AAGCTCTTCT GGGAAGCTCT 120 CATTCTCCTT CAGCCTCTGT ATCTCCTTCA TTCATCATCA CCAGTAGCTA TAGAAAAAAC 180 CCCACCATTG CGTTTAAGGT GCTTTCGTGG ATTCTTTGTA CAGTGGAAGT AATAACTCTC 240 GACTATATCC TCCTATATTG TGTCTTAAAA AGAGTGGCAA TGACAACTCT GGAAGTTGCT 300 CTCCTTCATA CTGCATTGAG CAAATGTGCA GAAACAAAAT GTTTTCTCAG CCAAACTGGA 360 GGCATAGCAA ACTATTCATT GATAAGCAAA GTTTTCTGGT TACACAAAAT GGCTTAGCTT 420 TTCTACCAAG AAAATTCAGA ACCATTCTCC GCAAAACAGT AAAACATTCA GAAATATTTA 480 GGAATATAGT ACCTGATATA TTTGTTCGGT CCTGCATTGG ACTAATGCTG GTTATGGCAC 540 TTAATGCTGC TGTTGCAAAA GCTCCTTCTT TTGCTCTCAC TGAACAAAAT CTGCTTTTCT 600 TGGAGGCATG GAGAACAATT GACCGTGCAT ATATTGACAA GACCTTCAAT GGTCAAAGTT 660 GGTTTAGGTA CAGAGAAGAT GCACTACGGA AAGAACCAAT GAACACTAGA CAGGAAACGT 720 ATGCAGCAAT AAAAAAGATG ATTGCCACTC TGGATGACCC TTTTACCCGT TTTCTGGAGC 780 CTGAAAAGTT TAAAAGTTTG CGGTCCGGAA CTCAAAATGC ACTTACTGGA GTAGGGTTGT 840 CAATTGGCTA TCCAACAGGA AAAACTGAAT CAGCTCCTGG ACTGGTCGTC GTCTCAGCTT 900 CTCCAGGAGG TTCTGCAGAT AGGGTCTGGC ATCTCATCGG TGATATTATC CTAGAAATTG 960 ACAATTCCAG CACAGATAAC ATGGGTATAT ATGATGCAGC AGAACGGTTA CAAGGACCTG 1020 AAGGAAGTGG TGTGGAACTA ACTGTACGTC GTGGATCCGA GACAAGGAAC CTACCATTGA 1080 TACGGGAGAA AGTTTTGCTT AATCCTGTAA AATCAAGAAT CTGCAAGCTG CCCACGGGAG 1140 GAGATGATGC TCCACAGATT GGATACATCA AACTATCAAC ATTCAACCAA AATGCTTCTG 1200 GTGCTGTAAG AGAAGCGATC GAAGCCTTAA GGAAAAACAA TGTTAATGCC TTTGTGTTGG 1260 ACCTTCGGGA TAATAGTGGT GGTCTCTTCC CAGAAGGAGT TGAGATACGA AAAATTTGGT 1320 TAAACAAGGG TGTGATTGTA TACATTTGTG ATAGCCGTGG TGTTCGAGAT ATTTATGACA 1380 CGGATGGGAG CAATGTGGTA GCTGCTTCAG AACCCCTAGC AGTGCTGGTA AACAAAGGGA 1440 CTGCAAGCGC AAGTGAGATT TTAGCAGGTG CTTTGAAAGA TAATAAGCGA GCCCAGCTTT 1500 TTGGTGAACC AACATATGGC AAGGGTAAAA TCCAGTCAGT ATTCCAGCTA TCAGATGGCT 1560 CTGGCTTGGC TGTTACAGTT GCTCGGTATG AAACTCCTGC TCACAACGAT ATAGACAAGG 1620 TTGGTGTAAT TCCGGACCAT CCTTTGCCAG CTTCATTCCC AAAAGACGAC GAGAGCTTCT 1680 GTAACTGCCT TCTAAATCCT GCCTCTGCTT GCCACCTAAA CAGAGTCGAG CTATTCTCGA 1740 AATAACTACA TCCCTACAGT CTGAAGAAAA GATCTTGTTT TTCAACTTGT GTTTGTAGAT 1800 TCCATAGTTT CCATTTGATT CTTTTGGCAG ATGCAAGTTG GTGATTTTGC TTGCATGCAT 1860 CTGATGTCTG TACATACCAT GAACAAAGGA CAACTTCAAT TTCTATTGTT GAACTCTTGC 1920 TGTAATAGAA TCAAATTCAA TAGTTTATCA ATCATCTTTT GAACTCTAAA GCAAAAAAAA 1980 AAAAAAAAAC TCGA 1994 (2) INFORMATION FOR SEQ ID NO: 15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 473 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (vi) ORIGINAL SOURCE: (B) STRAIN: TOBACCO Dl PROTEASE PROTEIN (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 15: Met Cys Arg Asn Lys Met Phe Ser Gin Pro Asn Trp Arg His Ser Lys 1 5 10 15 Leu Phe He Asp Lys Gin Ser Phe Leu Val Thr Gin Asn Gly Leu Ala 20 25 30 Phe Leu Pro Arg Lys Phe Arg Thr He Leu Arg Lys Thr Val Lys His 35 40 45 Ser Glu He Phe Arg Asn He Val Pro Asp He Phe Val Arg Ser Cys 50 55 60 He Gly Leu Met Leu Val Met Ala Leu Asn Ala Ala Val Ala Lys Ala 65 70 75 80 Pro Ser Phe Ala Leu Thr Glu Gin Asn Leu Leu Phe Leu Glu Ala Trp 85 90 95 Arg Thr He Asp Arg Ala Tyr He Asp Lys Thr Phe Asn Gly Gin Ser 100 105 110 Trp Phe Arg Tyr Arg Glu Asp Ala Leu Arg Lys Glu Pro Met Asn Thr 115 120 125 Arg Gin Glu Thr Tyr Ala Ala He Lys Lys Met He Ala Thr Leu Asp 130 135 140 Asp Pro Phe Thr Arg Phe Leu Glu Pro Glu Lys Phe Lys Ser Leu Arg 145 150 155 160 Ser Gly Thr Gin Asn Ala Leu Thr Gly Val Gly Leu Ser He Gly Tyr 165 170 175 Pro Thr Gly Lys Thr Glu Ser Ala Pro Gly Leu Val Val Val Ser Ala 180 185 190 Ser Pro Gly Gly Ser Ala Asp Arg Val Trp His Leu He Gly Asp He 195 200 20 He Leu Glu He Asp Asn Ser Ser Thr Asp Asn Met Gly He Tyr Asp 210 215 220 Ala Ala Glu Arg Leu Gin Gly Pro Glu Gly Ser Gly Val Glu Leu Thr 225 230 235 240 Val Arg Arg Gly Ser Glu Thr Arg Asn Leu Pro Leu He Arg Glu Lys 245 250 255 Val Leu Leu Asn Pro Val Lys Ser Arg He Cys Lys Leu Pro Thr Gly 260 265 270 Gly Asp Asp Ala Pro Gin He Gly Tyr He Lys Leu Ser Thr Phe Asn 275 280 285 Gin Asn Ala Ser Gly Ala Val Arg Glu Ala He Glu Ala Leu Arg Lys 290 295 300 Asn Asn Val Asn Ala Phe Val Leu Asp Leu Arg Asp Asn Ser Gly Gly 305 310 315 320 Leu Phe Pro Glu Gly Val Glu He Arg Lys He Trp Leu Asn Lys Gly 325 330 335 Val He Val Tyr He Cys Asp Ser Arg Gly Val Arg Asp He Tyr Asp 340 345 350 Thr Asp Gly Ser Asn Val Val Ala Ala Ser Glu Pro Leu Ala Val Leu 355 360 365 Val Asn Lys Gly Thr Ala Ser Ala Ser Glu He Leu Ala Gly Ala Leu 370 375 380 Lys Asp Asn Lys Arg Ala Gin Leu Phe Gly Glu Pro Thr Tyr Gly Lys 385 390 395 400 Gly Lys He Gin Ser Val Phe Gin Leu Ser Asp Gly Ser Gly Leu Ala 405 410 415 Val Thr Val Ala Arg Tyr Glu Thr Pro Ala His Asn Asp He Asp Lys 420 425 430 Val Gly Val He Pro Asp His Pro Leu Pro Ala Ser Phe Pro Lys Asp 435 440 445 Asp Glu Ser Phe Cys Asn Cys Leu Leu Asn Pro Ala Ser Ala Cys His 450 455 460 Leu Asn Arg Val Glu Leu Phe Ser Lys 465 470 (2) INFORMATION FOR SEQ ID NO: 16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 16: CAGCCATGGC GCTCACGGAG GAGAAC 26 (2) INFORMATION FOR SEQ ID NO: 17: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 17: ATACTTGGGA TCCATATCAC G 21 (2) INFORMATION FOR SEQ ID NO: 18: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 16 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 18: Glu Val Met His Glu Arg Asn Ala His Asn Phe Pro Leu Asp Leu Ala 1 5 10 15 (2) INFORMATION FOR SEQ ID NO: 19: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1864 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: SPINACH Dl PROTEASE GENE (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 19: GTTTCAATGG AGGTTATCTC GCGCCTCACC TTTGCTTCCG TTTCTTATCC CTTCATTTCT 60 TCCAACCTTA ATCCAACACC CATGCTCAAT TCTTTCAATT TCAGGGTGCT TTCCTGGAAC 120 AGTGCCCCCA CAAATGTTGC AGAAGCTCAT CTCCACCGCC TTTTACTGAG GAAATTGAAT 180 CCTGCTAATG ATCGGGTTGT TGGGATCTCT AACTTTGGTT GTTCATGCCG GTTAGATCTT 240 TGGCCAAGTT GGAGACGTCA TAAGAGGTTA TTTTTCCAGA ATGGTGTATC TACAATAAGG 300 TGGGAGGTCA AGAAGTGCAG TCCCAAATTT TATAAGATAG TCAGCAACTA TGAAAAATGC 360 AAACGTCATA TCTATGTCCC CTTTGTTCGT TTGGTTGTTG GAGTTGTATT GCTTATGTCT 420 GTTTCCGTAG CTTTAAACCA GGGCCCATCT TGGTCCCTTT CTGAGGAGAA TCGAATTTTC 480 CTAGAAGCGT GGAGAACAAT AGATCGTGCT TATGTTGACA AAACTTTTAA TGGACAAAGT 540 TGGTTTCGCT ATAGGGAGAA TGCACTGCGC AATGAGCCGA TGAACAGCAG AGAAGAGACA 600 TATACCGCAA TAAGAAAGAT GGTTGCTACA CTGAATGATC CATTCACTCG TTTTCTGGAA 660 CCCGAAAAAT TAAAGAGTTT GCGGTCTGGA ACTCAGAGTT CGCTTACGGG TGTAGGGATA 720 TCTATTGGCC CCACCGCCGT TGACCAATCA TCCACTGGAT TAGTTGTAAT CTCAGCTACT 780 CCTGGGGCTC CTGCCAGTAG GGCCGGCATC TTGCCTGGTG ATGTAATATT GGCAATTGAT 840 GATGCAAGTA CTGACAAAAT GGGCATATAT GAGGCAGCAA ATATCTTACA GGGACCTGAT 900 GGAAGTTCTG TTGATTTGAC TATTTGCAGC AGGGATGAGA TAAAACATGT GGTGCTGAAG 960 CGTGAGAGAA TAACTCTAAG CCCAGTAAAA TCCAGATTAT GTGAGATGCC TGGTTCAGCA 1020 AAGGATGCTC CTCCAAAAGT TGGATATATC AAGTTAACAT CGTTCACTGA GAATGCTTCT 1080 GATGCAGTAA AGGAAGCTAT AGAGACACTT AGAAGTAACA ATGTTAATGC TTTTGTGCTG 1140 GACCTTCGAG ATAATAGCGG TGGTCTCTTT CCAGAGGGAA TCGAGATAGC CAAAATTTGG 1200 TTGAACAAAG GAGTTATTGT ATATATATGT GATAGTCGTG GTGTTCGTGA TATATATGAT 1260 GTTGAAGGGA GCAGTGCTGT AGCTGGTTCA GAACCTCTTG TTGTTCTGGT GAACAAGGGA 1320 ACTGCAAGTG CTAGTGAAAT ATTAGCTGGG GCATTAAAGG ACAACAAACG AGCAGTGGTA 1380 TTTGGAGAGC CCACATATGG AAAGGGCAAG ATACAGTCAG TTTTCGAGCT ATCTGATGGA 1440 TCTGGCTTAG CAGTCACAGT TGCTCGCTAT GAGACTCCTG CTCACACAGA TATTGACAAG 1500 GTGGGAATCA AACCAGATCA TCCTCTCCCA GCATCTTTTC CAAAGGATGA AAATGATTTC 1560 TGCACCTGCG TCCAAGATCC ATCGTCTACT TGTTATCTCA ACGGCGTACA ACTCTTTTCA 1620 AGATGACTAT GGAAATGAAT TTCTTCGGTG TTTTCCATTT GCGTTGCAAA TTTTGGTTCT 1680 TTTAAAATTA CTATTTTTTC AGGATGCTAG CCATCTCTGT TGTAAGTTTG TAACATCATT 1740 GGTTCCTTGT ATATCTCTTC ATCATCGTTC CAACATCATA GATTCTTTGT ATATCTCTTT 1800 ATCGTCGTTC GCGAAATTCA GCATGGATTA TCTTTTATCA AACAATCTAA CTTTGAGTAA 1860 ATCT 1864 (2) INFORMATION FOR SEQ ID NO: 20: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 539 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (vi) ORIGINAL SOURCE: (B) STRAIN: SPINACH Dl PROTEASE PROTEIN (xi) SEQUENCE DESCRIPTION: SEQ ID NO:20: Met Glu Val He Ser Arg Leu Thr Phe Ala Ser Val Ser Tyr Pro Phe 1 5 10 15 He Ser Ser Asn Leu Asn Pro Thr Pro Met Leu Asn Ser Phe Asn Phe 20 25 30 Arg Val Leu Ser Trp Asn Ser Ala Pro Thr Asn Val Ala Glu Ala His 35 40 45 Leu His Arg Leu Leu Leu Arg Lys Leu Asn Pro Ala Asn Asp Arg Val 50 55 60 Val Gly He Ser Asn Phe Gly Cys Ser Cys Arg Leu Asp Leu Trp Pro 65 70 75 80 Ser Trp Arg Arg His Lys Arg Leu Phe Phe Gin Asn Gly Val Ser Thr 85 90 95 He Arg Trp Glu Val Lys Lys Cys Ser Pro Lys Phe Tyr Lys He Val 100 105 110 Ser Asn Tyr Glu Lys Cys Lys Arg His He Tyr Val Pro Phe Val Arg 115 120 125 Leu Val Val Gly Val Val Leu Leu Met Ser Val Ser Val Ala Leu Asn 130 135 140 Gin Gly Pro Ser Trp Ser Leu Ser Glu Glu Asn Arg He Phe Leu Glu 145 150 155 160 Ala Trp Arg Thr He Asp Arg Ala Tyr Val Asp Lys Thr Phe Asn Gly 165 170 175 Gin Ser Trp Phe Arg Tyr Arg Glu Asn Ala Leu Arg Asn Glu Pro Met 180 185 190 Asn Ser Arg Glu Glu Thr Tyr Thr Ala He Arg Lys Met Val Ala Thr 195 200 205 Leu Asn Asp Pro Phe Thr Arg Phe Leu Glu Pro Glu Lys Leu Lys Ser 210 215 220 Leu Arg Ser Gly Thr Gin Ser Ser Leu Thr Gly Val Gly He Ser He 225 230 235 240 Gly Pro Thr Ala Val Asp Gin Ser Ser Thr Gly Leu Val Val He Ser 245 250 255 Ala Thr Pro Gly Ala Pro Ala Ser Arg Ala Gly He Leu Pro Gly Asp 260 265 270 Val He Leu Ala He Asp Asp Ala Ser Thr Asp Lys Met Gly He Tyr 275 280 285 Glu Ala Ala Asn He Leu Gin Gly Pro Asp Gly Ser Ser Val Asp Leu 290 295 300 Thr He Cys Ser Arg Asp Glu He Lys His Val Val Leu Lys Arg Glu 305 310 315 320 Arg He Thr Leu Ser Pro Val Lys Ser Arg Leu Cys Glu Met Pro Gly 325 330 335 Ser Ala Lys Asp Ala Pro Pro Lys Val Gly Tyr He Lys Leu Thr Ser 340 345 350 Phe Thr Glu Asn Ala Ser Asp Ala Val Lys Glu Ala He Glu Thr Leu 355 360 365 Arg Ser Asn Asn Val Asn Ala Phe Val Leu Asp Leu Arg Asp Asn Ser 370 375 380 Gly Gly Leu Phe Pro Glu Gly He Glu He Ala Lys He Trp Leu Asn 385 390 395 400 Lys Gly Val He Val Tyr He Cys Asp Ser Arg Gly Val Arg Asp He 405 410 415 Tyr Asp Val Glu Gly Ser Ser Ala Val Ala Gly Ser Glu Pro Leu Val 420 425 430 Val Leu Val Asn Lys Gly Thr Ala Ser Ala Ser Glu He Leu Ala Gly 435 440 445 Ala Leu Lys Asp Asn Lys Arg Ala Val Val Phe Gly Glu Pro Thr Tyr 450 455 460 Gly Lys Gly Lys He Gin Ser Val Phe Glu Leu Ser Asp Gly Ser Gly 465 470 475 480 Leu Ala Val Thr Val Ala Arg Tyr Glu Thr Pro Ala His Thr Asp He 485 490 495 Asp Lys Val Gly He Lys Pro Asp His Pro Leu Pro Ala Ser Phe Pro 500 505 510 Lys Asp Glu Asn Asp Phe Cys Thr Cys Val Gin Asp Pro Ser Ser Thr 515 520 525 Cys Tyr Leu Asn Gly Val Gin Leu Phe Ser Arg 530 535 (2) INFORMATION FOR SEQ ID NO: 21: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 128 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 21: Gly Thr Ala Gly Ser Val Thr Gly Val Gly Leu Glu He Thr Tyr Asp 1 5 10 15 Gly Gly Ser Gly Gly Leu Ser Leu Tyr Asp Val Ser Asp Leu Leu Gin 20 25 30 Gly Glu Ala Asp Ser Gin Val Glu Val Val Leu His Ala Pro Gly Ala 35 40 45 Pro Ser Asn Thr Arg Leu Ala Thr Phe Asn Ser Asn Thr Thr Ala Ala 50 55 60 Ala Gin Gin Ala Phe Thr Glu Leu Ser Asp He Tyr Ser Ala Asp Gly 65 70 75 80 Asn Ser He Asp Ser Ala Thr Pro Leu Val Val Leu Val Asn Arg Leu 85 90 95 He Gin Thr Val Val Asp Leu Ser Asp He Gly Val Ser Pro Asp Val 100 105 110 Gin Leu Asp Pro Glu Val Leu Pro Thr Asp Leu Glu Gly Val Cys Arg 115 120 125 (2) INFORMATION FOR SEQ ID NO: 22: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 464 ammo acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 22: Met His Ser Arg Thr Asn Cys Leu Gin Thr Ser Val Arg Ala Pro Gin 1 5 10 15 Pro His Phe Arg Pro Phe Thr Ala Val Lys Thr Cys Arg Gin Arg Cys 20 25 30 Ser Thr Thr Ala Ala Ala Ala Lys Arg Asp Gin Ala Gin Glu Gin Gin 35 40 45 Pro Trp He Gin Val Gly Leu Gly Leu Ala Ala Ala Ala Thr Ala Val 50 55 60 Ala Val Gly Leu Gly Ala Ala Ala Leu Pro Ala Gin Ala Val Thr Ser 65 70 75 80 Glu Gin Leu Leu Phe Leu Glu Ala Trp Arg Ala Val Asp Arg Ala Tyr 85 90 95 Val Asp Lys Ser Phe Asn Gly Gin Ser Trp Phe Lys Leu Arg Glu Thr 100 105 110 Tyr Leu Lys Arg Glu Pro Met Asp Arg Arg Ala Gin Thr Tyr Asp Ala 115 120 125 He Arg Lys Leu Leu Ala Val Leu Asp Asp Pro Phe Thr Arg Phe Leu 130 135 140 Glu Pro Ser Arg Leu Ala Ala Leu Arg Arg Gly Thr Ala Gly Ser Val 145 150 155 160 Thr Gly Val Gly Leu Glu He Thr Tyr Asp Gly Gly Ser Gly Arg Asp 165 170 175 Val Val Val Leu Thr Pro Ala Pro Gly Gly Pro Ala Glu Arg Ala Gly 180 185 190 Ala Arg Ala Gly Asp Val He Val Thr Val Asp Gly Thr Ala Val Lys 195 200 205 Gly Leu Ser Leu Tyr Asp Val Ser Asp Leu Leu Gin Gly Glu Ala Asp 210 215 220 Ser Gin Val Glu Val Val Leu His Ala Pro Gly Ala Pro Ser Asn Thr 225 230 235 240 Arg Thr Leu Gin Leu Thr Arg Gin Lys Val Thr He Asn Pro Val Thr 245 250 255 Phe Thr Thr Cys Ser Asn Val Ala Ala Ala Ala Leu Pro Pro Gly Ala 260 265 270 Ala Arg Gin Gin Leu Gly Tyr Val Arg Leu Ala Thr Phe Asn Ser Asn 275 280 285 Thr Thr Ala Ala Ala Gin Gin Ala Phe Thr Glu Leu Ser Lys Gin Gly 290 295 300 Val Ala Gly Leu Val Leu Asp He Arg Asn Asn Gly Gly Gly Leu Phe 305 310 315 320 Pro Ala Gly Val Asn Val Ala Arg Met Leu Val Asp Arg Gly Asp Leu 325 330 335 Val Leu He Ala Asp Ser Gin Gly He Arg Asp He Tyr Ser Ala Asp 340 345 350 Gly Asn Ser He Asp Ser Ala Thr Pro Leu Val Val Leu Val Asn Arg 355 360 365 Gly Thr Ala Ser Ala Ser Glu Val Leu Ala Gly Ala Leu Arg Asp Ser 370 375 380 Lys Arg Gly Leu He Ala Gly Glu Arg Thr Phe Gly Lys Gly Leu He 385 390 395 400 Gin Thr Val Val Asp Leu Ser Asp Gly Ser Gly Val Ala Val Thr Val 405 410 415 Ala Arg Tyr Gin Thr Pro Ala Gly Val Asp He Asn Lys He Gly Val 420 425 430 Ser Pro Asp Val Gin Leu Asp Pro Glu Val Leu Pro Thr Asp Leu Glu 435 440 445 Gly Val Cys Arg Val Leu Gly Ser Asp Ala Ala Pro Arg Leu Phe Gly 450 455 460 (2) INFORMATION FOR SEQ ID NO:23: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 60 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:23: CTGAAGGACA GCAAGCGGGG CCTCATAGCT GGCGAGCGCA CCTTTGGCAA GGGCCTCATT 60 (2) INFORMATION FOR SEQ ID NO: 24: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown ( ii ) MOLECULE TYPE : peptide ( xi ) SEQUENCE DESCRI PTION : SEQ I D NO : 24 : Leu Lys Asp Ser Lys Arg Gly Leu He Ala Gly Glx Arg Thr Phe Gly 1 5 10 15 Lys Gly Leu He 20 (2) INFORMATION FOR SEQ ID NO: 25: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 59 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:25: CTCAAGGACA GCAAGCGGGC CTCATAGCTG GCGAGCGCAC CTTTGGCAAG GGCCTCATT 59 (2) INFORMATION FOR SEQ ID NO: 26: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 8 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (11) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26: Leu Lys Asp Ser Lys Arg Ala Ser 1 5 (2) INFORMATION FOR SEQ ID NO: 27: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 60 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 27: CTCAAGCACA GCAAGCGGGC CTCATTAGCT GGCGAGCGCA CCTTTGGCAA GGGCCTCATT 60 (2) INFORMATION FOR SEQ ID NO: 28: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 ammo acids (B) TYPE: ammo acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 28: Leu Lys Asp Ser Lys Arg Ala Ser Leu Ala Gly Glx Arg Thr Phe Gly 1 5 10 15 Lys Gly Leu He 20 (2) INFORMATION FOR SEQ ID NO: 29: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 16 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:29: GCCCGATCGC CTCATA 16 INDICATIONS RELATING TO A DEPOSITED MICROORGANISM (PCT Rule \ 3bιs) 1 he indications made below relate to the microorganism referred to in the description on page 5 , line _11 B. IDENTIFICATION OF DEPOSIT Further deposits are identified on an additional sheet | | Name of depositary institution AMERICAN TYPE CULTURE COLLECTION Address of depositary institution (including postal code and country) 12301 Par lawn Drive Rockville, Maryland 20852 US Dale of deposit Accession Number 26 September 1996 (26.09.96) 98186 C. ADDITIONAL INDICATIONS (leave blank if not applicable) This information is continued on an additional sheet ~J In respect of those designations in which a European patent is sought, a sample of the deposited microorganism will be made available until the publication of the mention of the grant of the European patent or until the * date on which the application has been refused or withdrawn or is deemed to be withdrawn, only by the issue of such a sample to an expert nominated by the person requesting the sample. (Rule 28(4) EPC) D. DESIGNATED STATES FOR WHICH INDICATIONS ARE MADE (if the indications are not for ail designated States) E. SEPARATE FURNISHING OF INDICATIONS (leave blank if not applicable) The indications listed below will be submitted to the International Bureau later (specify the general nature o the indications e g "Accession Number of Deposit") For receiving Office use only For International Bureau use onlv I [ This sheet was received with the international application I I This sheet was received by the International Bureau on Authorized officer Authorized officer l orm PCT RO/l34 (July 1992)

Claims: WHAT IS CLAIMED IS: 1. A method for identifying a herbicidal agent which inhibits Dl protease comprising: a) incubating an effective amount of a Dl protease enzyme in a sample suspected of containing a herbicidal agent with a suitable Dl enzyme substrate wherein an enzyme product is formed; and b) detecting and quantifying the enzyme product of step a) with means appropriate for the enzyme product. 2. The method of Claim 1 wherein the suitable Dl enzyme substrate is a thylakoid membrane containing unprocessed Dl polypeptide and wherein the incubating step a) is performed at about pH 4.0 to about pH 6.0. 3. The method of Claim 1 wherein the suitable Dl enzyme substrate is a photosystem II core complex containing unprocessed Dl polypeptide and wherein the incubating step a) is performed at about pH 6.0 to about pH 8.0. 4. The method of Claim 1 wherein the suitable Dl enzyme substrate is a peptide or peptide analogue containing a Dl protein or a Dl pre-protein processing site. 5. The method of Claim 1 wherein the suitable Dl enzyme substrate is immobilized on a suitable support. 6. The method of Claim 1 wherein the suitable Dl enzyme substrate is in solution or homogeneously suspended. 7. The method of Claim 5 wherein the suitable support is selected from group consisting of polystyrene, substituted polystyrene, polypropylene, polyglycidylmethacrylate, agarose, nitrocellulose, nylon, magnetic and nonmagnetic particles. 8. The method of Claim 1 wherein the Dl protease enzyme is isolated from an organism selected from the group consisting of higher plants, algae and cyanobacteria. 9. The method of Claim 8 wherein the D 1 protease enzyme is isolated from a higher plant selected from the group consisting of soybean, rapeseed, sunflower, cotton, corn, tobacco, alfalfa, wheat, barley, oats, sorghum, rice, cruciferous vegetables, broccoli, cauliflower, cabbage, parsnips, tomato, potato, spinach, alfalfa, sorghum, hardwood and softwood trees, and forage grasses. 10. The method of Claim 8 wherein the Dl protease enzyme is isolated from an organism selected from the group consisting of wheat, Scenedesmus, Synechocystis, tobacco, and spinach. 11. The method of Claim 1 wherein the enzyme product is the mature Dl polypeptide or the C-terminal tail of the processed Dl pre-protein. 12. The method of Claim 11 wherein the enzyme product is mature D 1 polypeptide and the detecting step b) is by absorbant, fluorescent, or chemiluminscent means. 13. The method of Claim 11 wherein the enzyme product is the C-terminal tail of the processed Dl pre-protein and the detecting step b) is by fluorescent means. 14. A method for detecting in vivo a herbicidal agent which inhibits Dl protease comprising: (a) mixing a reaction mixture comprising: (i) a wildtype cell comprising: (A) an active Dl protease enzyme capable of processing a Dl pre-protein; and (B) a Photosystem II core complex capable of variable chlorophyll fluorescence; (ii) a suspected herbicidal agent which inhibits Dl protease; (iv) suitable growth medium; (b) illuminating the reaction mixture at illumination conditions of and for a time sufficient to permit Dl turnover; and (c) measuring the variable chlorophyll fluorescence produced in step (b), whereby the level of the variable chlorophyll fluorescence correlates with herbicidal activity of the suspected herbicidal agent. 15. The method of Claim 14 wherein at step (a) the reaction mixture further comprises: (v) a mutant cell comprising: (A) an inactive Dl protease enzyme characterized by an inability to process a Dl pre-protein; and (B) a Photosystem II core complex capable of variable fluorescence. 16. The method of Claim 15 wherein the mutant cell is LF- 1 Scenedesmus. 17. The method of Claims 14 and 15 wherein the wildtype cell is selected from the group consisting of soybean, rapeseed, sunflower, cotton, corn, tobacco, alfalfa, wheat, barley, oats, sorghum, rice, cruciferous vegetables, broccoli, cauliflower, cabbage, parsnips, tomato, potato, spinach, alfalfa, sorghum, hardwood and softwood trees, forage grasses, algae and cyanobacteria. 18. The method of Claim 17 wherein the wildtype cell is selected from the group consisting of wheat, tobacco, spinach, and Scenedesmus, and Synechocystis. 19. A method for the recombinant production of Dl protease enzyme comprising: (a) transforming a suitable host cell with a vector comprising a gene encoding a Dl protease enzyme, the gene operably linked to at least one suitable regulatory sequence; (b) culturing the transformed cell of step (a) under conditions wherein Dl protease is expressed; and (c) recovering the Dl protease expressed in step (b). 20. The method of Claim 19 wherein the suitable host cell is selected from the group consisting of Escherichia, Bacillus, Klebsiella, fungi, yeasts, and insects. 21. The method of Claim 19 wherein the gene encoding a D 1 protease enzyme is isolated from an organism selected from the group consisting of higher plants, algae, and cyanobacteria. 22. The method of Claim 21 wherein the gene encoding a Dl protease enzyme is isolated from an organism selected from the group consisting of wheat, tobacco, spinach, Scenedesmus, and Synechocystis. 23. The method of Claim 19 wherein the gene encoding a Dl protease enzyme encodes the amino acid sequences of SEQ ID NO:9, SEQ ID NO: 15, SEQ ID NO:4, SEQ ID NO: 13 and SEQ ID NO:20 wherein the amino acid sequences encompass amino acid substitutions, deletions, or additions that do not alter the function of the Dl protease enzyme. 24. The method of Claim 21 wherein the gene encoding a Dl protease enzyme is selected from the group of nucleotide sequences consisting of SEQ ID NO:8, SEQ ID NO:14, SEQ ID NO:3, SEQ ID NO:12, and SEQ ID NO:19. 25. A gene encoding a Dl protease enzyme which encodes the amino acid sequences of one of SEQ ID NO:9, SEQ ID NO: 15, SEQ ID NO:4, and SEQ ID NO: 13 wherein the amino acid sequences encompass amino acid substitutions, deletions, or additions that do not alter the function of the Dl protease. 26. A gene encoding a Dl protease enzyme selected from the group of nucleotide sequences consisting of SEQ ID NO:8, SEQ ID NO: 14, SEQ ID NO:3, and SEQ ID NO: 12. 27. A transformed cell comprising a suitable host cell and the gene of Claims 25 or 26. 28. The transformed cell of Claim 27 wherein the suitable host cell is selected from the group consisting of Escherichia, Bacillus, Klebsiella, fungi, yeasts and insects. 29. A transformed E. coli cell corresponding to the biological deposit designated ATCC 98186 comprising a gene encoding the wheat Dl protease enzyme. 30. A method for detecting in vivo a herbicidal agent which inhibits Dl protease comprising: (a) mixing a first reaction mixture comprising: (i) a wildtype Synechocystis comprising: (A) an active Dl protease enzyme capable of processing a Dl pre-protein; and (B) a Dl pre-protein; (ii) a suspected herbicidal agent which inhibits Dl protease; (iii) suitable growth medium; (b) mixing a second reaction mixture comprising: (i) a mutant Synechocystis expressing a mature D 1 protein which lacks the final 16 C-terminal amino acid residues of the Dl pre-protein and is devoid of a Dl protease processing site; (ii) a suspected herbicidal agent which inhibits Dl protease: (iii) suitable growth medium (b) illuminating the first and second reaction mixtures under the same illumination conditions and for a time sufficient to permit cell growth; and (c) comparing the cell growth of the wildtype Synechocystis following step (b) with the cell growth of the mutant Synechocystis following step (b) wherein an inhibition of the growth of the wildtype Synechocystis as compared with the mutant Synechocystis indicates the suspected herbicidal agent has Dl protease inhibiting activity.

Inventors: CHISHOLM DEXTER ALLAN, DINER BRUCE AARON, DONALDSON GAIL K, HERSHEY HOWARD PAUL, JORDAN DOUGLAS BRIAN, TANG XIAO SONG, TROST JEFFREY T, WANG SHAOJIE, WARREN PATRICK V, CHISHOLM, DEXTER, ALLAN, DINER, BRUCE, AARON, DONALDSON, GAIL, K., HERSHEY, HOWARD, PAUL, JORDAN, DOUGLAS, BRIAN, TANG, XIAO, SONG, TROST, JEFFREY, T., WANG, SHAOJIE, WARREN, PATRICK, V.
Applicants: CHISHOLM DEXTER ALLAN, DINER BRUCE AARON, DONALDSON GAIL K, DU PONT, HERSHEY HOWARD PAUL, JORDAN DOUGLAS BRIAN, TANG XIAO SONG, TROST JEFFREY T, WANG SHAOJIE, WARREN PATRICK V, CHISHOLM, DEXTER, ALLAN, DINER, BRUCE, AARON, DONALDSON, GAIL, K., E.I. DU PONT DE NEMOURS AND COMPANY, HERSHEY, HOWARD, PAUL, JORDAN, DOUGLAS, BRIAN, TANG, XIAO, SONG, TROST, JEFFREY, T., WANG, SHAOJIE, WARREN, PATRICK, V.
Application year: 1997
Main classification: C12Q1
IPC codes: C07H21, C12Q1, G01N33